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Bovine herpesvirus 1 (BHV-1) is a significant pathogen of cattle.  Following 
acute infection, BHV-1 establishes a latent infection that persists for the life of the 
infected host.  Stress induced factors cause the virus to reactivate from latency, resulting 
in virus transmission and transient immune suppression.  BHV-1 encoded bICP0 is 
expressed early and constitutively throughout productive infection.  bICP0 is critical for 
efficient viral replication, virulence, and reactivation in cattle because it stimulates viral 
transcription and interferes with innate immune responses.  bICP0 potentially interacts 
with a variety of proteins to activate viral gene expression and inhibit innate antiviral 
defenses.  bICP0 localizes to promyelocytic leukemia (PML) protein-containing nuclear 
domains, which are associated with antiviral activity and commonly targeted for 
disruption by a wide variety of viruses.  The zinc RING finger motif within bICP0 plays 
a critical role in the biological functions of bICP0, and possesses intrinsic E3 ubiquitin 
ligase activity that is important for polyubiquitination and subsequent degradation of 
proteins.   
Results from these studies demonstrated mutations within the zinc RING finger 
increased bICP0 protein levels, presumably due to disruption of the ability of bICP0 to 
induce its own ubiquitination.  Sequences at its C-terminus are also important for 
regulating the half-life of bICP0.  BHV-1 infection and bICP0 expression alone reduced 
PML protein levels.  Unexpectedly, bICP0 mutants that localized primarily in the 
cytoplasm also induced PML degradation.  bICP0 was readily detected in the cytoplasm 
of low passage bovine cells at later times post infection, suggesting bICP0 induces 
degradation of cytoplasmic isoforms of PML to promote viral replication.  Identification 
of bICP0-interacting proteins was also investigated to further elucidate the mechanisms 
underlying bICP0 functions.  The ability of BHV-1 and a bICP0 zinc RING finger mutant 
to grow in oncogenic cells was also examined to determine if defects in viral growth of 
the mutant could be relieved in cells with potential defects in their interferon response.  
Collectively, studies presented in this dissertation determine that nuclear and cytoplasmic 
bICP0 have functions that promote productive infection. 
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I.  Introduction 
Bovine herpesvirus type 1 (BHV-1) is a significant pathogen of cattle.  
Herpesviruses have linear, double-stranded DNA genomes and replicate in the nucleus of 
infected cells.  The hallmark of all herpesviruses is their ability to establish a latent 
infection that persists for the lifetime of the infected host.  Stress-induced factors cause 
the virus to reactivate from latency, resulting in recurrent lytic infection and transmission 
of the virus.  Three subfamilies make up the family Herpesviridae:  Alphaherpesvirinae, 
Betaherpesvirinae, and Gammaherpesvirinae.  Each herpesvirus subfamily is unique in 
the length of their replication cycle and the subset of cells in which latency is established.  
Members of the subfamily Betaherpesvirinae have long replication cycles compared to 
the other Herpesviridae subfamilies and establish latency in leukocytes.  
Gammaherpesvirinae members infect immune cells such as B-lymphocytes, and include 
Epstein-Barr virus (EBV), which causes mononucleosis, and Kaposi’s sarcoma-
associated herpesvirus (KSHV) commonly found in AIDS patients.  Alphaherpesvirinae 
subfamily members are neurotropic, have a short replication cycle, and induce severe 
cytopathology.  In addition to BHV-1, other clinically important Alphaherpesvirinae 
members include the pathogens:  human Herpes simplex virus types 1 and 2 (HSV-1, 
HSV-2) and Varicella zoster virus (VZV) the causative agent of “chicken pox” and 
“shingles”, Pseudorabies virus (PRV) which infects pigs, and equine herpesvirus 1 
(EHV-1) of horses.   
The Alphaherpesvirinae subfamily members listed above all encode infected cell 
protein 0 (ICP0)-related proteins that are characterized by the presence of a zinc RING 
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(which stands for “really interesting novel gene”) finger domain and their ability to 
activate viral transcription (Everett et al., 2010).  These proteins also have inherent E3 
ubiquitin ligase activity and interact with promyelocytic leukemia (PML) protein-
containing nuclear structures (Everett et al., 2010).  The biology of BHV-1 encoded 
bICP0 and its role in infection are discussed in this literature review. 
 
II.  Overview of BHV-1 infection  
A.  Pathogenesis and immune evasion 
BHV-1 is a pathogen of cattle that contributes to considerable economic losses to 
the cattle industry every year (Jones and Chowdhury, 2007; Turin et al., 1999).  Clinical 
disease associated with BHV-1 infection includes conjunctivitis, respiratory infection and 
pneumonia, genital and reproductive disorders, abortions, and in rare cases encephalitis 
(Tikoo et al., 1995).  BHV-1 is subdivided into three subtypes:  BHV-1.1 is associated 
with respiratory disease, BHV-1.2a is most commonly linked to genital infections, and 
the less pathogenic BHV-1.2b strains (Jones and Chowdhury, 2007).  BHV-1 infection 
causes suppression of the host’s immune defenses and as a consequence can lead to 
secondary infections (Carter et al., 1989; Griebel et al., 1990; Griebel et al., 1987b; 
Griebel et al., 1987c).  Bovine respiratory disease (BRD) or “Shipping Fever” is an upper 
respiratory infection complex that can be initiated by BHV-1 infection (Jones and 
Chowdhury, 2007; Muylkens et al., 2007; Yates, 1982).  BRD and BHV-1 infections cost 
the United States cattle industry approximately 3 billion dollars in losses annually 
((NASS), 1996; Bowland and Shewen, 2000; Carter et al., 1989; Griebel et al., 1987a; 
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Griebel et al., 1990; Griebel et al., 1987c; Ishmael, 2001; Kapil, 1997; Powell, 2005; Tikoo 
et al., 1995; Turin et al., 1999).  BHV-1 modified live attenuated virus or killed virus 
vaccines that protect against clinical disease in adults are commercially available (Jones 
and Chowdhury, 2007).  However, BHV-1 vaccination can cause immune suppression 
leading to serious disease in young calves or abortions in pregnant cows (Jones and 
Chowdhury, 2007; van Drunen Littel-van den Hurk, 2006).  In addition, modified live 
vaccines can reactivate from latency, be transmitted and cause disease in immune 
suppressed animals (Ellis et al., 2005; Muylkens et al., 2007; van Drunen Littel-van den 
Hurk et al., 2001).  The fact that BHV-1 establishes lifelong latent infection complicates 
the development of effective vaccines.   
BHV-1 interferes with immune recognition and innate immune response 
pathways (Jones, 2009).  CD4+ T cells are semi-permissive to BHV-1 and their infection 
by this virus results in apoptosis (Winkler et al., 1999).  BHV-1 encoded glycoprotein N 
impairs immune recognition of infected cells by interfering with MHC I antigen 
presentation to CD8+ T cells (Hariharan et al., 1993; Hinkley et al., 1998; Koppers-Lalic 
et al., 2005; Nataraj et al., 1997).  Glycoprotein G is secreted from BHV-1 infected cells 
and is able to bind a broad range of chemokines (Bryant et al., 2003); thus, potentially 
interfering with the activation of inflammatory and immune response pathways that lead 
to antiviral functions (Baggiolini, 1998).  BHV-1 infected protein cell protein 0 (bICP0) 
inhibits induction of interferon beta (IFN-) by interfering with transcriptional co-
activators, interferon regulatory factors 3 and 7 (IRF3, IRF7) and p300 (Henderson et al., 
2005; Saira et al., 2007; Saira et al., 2009; Zhang et al., 2006).  The latency related (LR) 
gene products also have a protective effect against apoptosis (Ciacci-Zanella et al., 1999; 
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Henderson et al., 2004a) and inhibit infiltration of inflammatory cells into the trigeminal 
ganglia of calves (Perez et al., 2006), the site where latency is established. 
 
B.  Productive infection 
BHV-1 productive infection occurs in mucosal surfaces of the eyes, respiratory 
tract, or genital tract.  During the acute lytic stage of infection, high levels of virus are 
produced and shed from the infected mucosal tissues for up to 10 days after infection 
(Jones, 1998; Jones, 2003).  The herpesvirus virion is composed of a DNA core 
surrounded by an icosahedral nucleocapsid, a tegument and an envelope.  The tegument 
is a proteinaceous matrix located between the capsid and envelope and contains important 
factors for initiating viral transcription (Valicek and Smid, 1976).  Glycoproteins of the 
viral envelope bind to receptors on the cell surface and fusion with the cellular membrane 
occurs.  The viral capsid is released into the cytosol, transported to the nucleus, and the 
viral DNA ejected into the nucleus where viral replication takes place.  During productive 
infection, viral genes are temporally expressed in three distinct phases: immediate early 
(IE), early (E), and late (L) (Jones, 1998; Jones, 2003; Wirth et al., 1989).  IE viral gene 
expression is initiated by the BHV-1 the virion component trans-inducing factor (bTIF) 
and cellular transcriptional activator Oct-1 (Misra et al., 1994; Misra et al., 1995).  IE 
proteins activate E gene expression, followed by viral DNA replication.  Late genes 
include structural proteins such as glycoproteins, nucleocapsid and tegument proteins 
important for virion assembly.  Subsequently, viral genomic DNA is packaged and 
encapsidated.  Following assembly in the nucleus, viral capsids migrates from the nucleus 
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to the cell surface, acquiring envelope from nuclear budding and secondary envelopment 
from compartments within the cytoplasm (Mettenleiter et al., 2009).  Finally, infectious 
virus particles are released. 
The BHV-1 genome is 135.3 kbp, 72% G + C rich, and encodes at least 70 known 
proteins (Meyer et al., 1997; Plummer et al., 1969).  The genome is divided into a unique 
long (L) and unique short (S) segment flanked with internal and terminal inverted repeats 
(Figure 1A).  Located within the inverted repeats are two IE transcription units (IEtu1, 
IEtu2).  IE genes encoded by IEtu1 and IEtu2 are alternatively spliced to give rise to 
three major IE proteins essential for regulating viral gene expression (Wirth et al., 1991).  
The IEtu1 transcript encodes BHV-1 infected cell protein 0 (bICP0) and bICP4 (Wirth et 
al., 1992).  bICP0 acts as a promiscuous transcriptional activator that stimulates all three 
classes (IE, E, and L) of viral promoters, whereas, expression of bICP4 represses IEtu1 
promoter activity (Fraefel et al., 1994; Wirth et al., 1992; Wirth et al., 1991).  The 
bICP22 protein is encoded by IEtu2 and acts as a trans-repressor of viral promoters from 
each class (Koppel et al., 1997).   
bICP0 is the major regulator of BHV-1 gene expression and is critical for efficient 
viral replication (Geiser et al., 2005; Saira et al., 2008).  During productive infection 
bICP0 is constitutively expressed, in part because it can activate its own promoters.  
Expression of bICP0 is under the control of the IEtu1 and E promoters (Figure 1A).  The 
bICP0 protein is translated from the alternatively spliced IE/2.9 transcript and the 
unspliced E/2.6 transcript (Wirth et al., 1991).  These two transcripts share an identical 
open reading frame (ORF) that expresses a 676 amino acid protein that migrates at 97 
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kDa (Wirth et al., 1992).  Although bICP0 is not required for viral replication, it is a 
critical factor of the BHV-1 infection cycle.  The functions of bICP0 are reviewed and 
discussed in more detail in the following sections. 
 
C.   Latency and reactivation 
Following productive infection, BHV-1 establishes a latent infection which allows 
the virus to persist for the life of the host.  Virus particles enter sensory neurons of the 
peripheral nervous system via cell-to-cell spread.  For acute infections that occur in the 
ocular or oronasal cavities, the trigeminal ganglion is the primary site for latency.  For 
genital infections, latency is established in the neurons associated with the sacral ganglia.  
During latency, lytic viral gene expression and production of infectious virions ceases.  
However, viral genome can be detected in the sensory ganglia (Inman et al., 2002; 
Schang and Jones, 1997), as well as other non-neuronal sites such as the tonsils (Winkler 
et al., 2000), peripheral blood (Fuchs et al., 1999), spleen and lymph nodes (Mweene et 
al., 1996).   
The latent stage of infection is marked by expression of the latency related (LR) 
gene and ORF-E, the only two transcripts known to be abundantly expressed during 
latency (Inman et al., 2004; Jones, 1998; Jones, 2003; Kutish et al., 1990).  Both ORFE 
and the LR produce proteins during latency (Meyer et al., 2007; Perez et al., 2007).  The 
LR gene contains two ORFs and two RFs that lack an initiating methionine (ATG).  LR 
transcripts can be alternatively spliced which potentially gives rise to multiple fusion 
proteins (Devireddy and Jones, 1998; Hossain et al., 1995).  The LR gene is anti-sense to 
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bICP0 and ORFE, and expression of the LR transcript is sufficient to inhibit bICP0 
expression (Bratanich et al., 1992; Geiser et al., 2002).  Two families of small non-coding 
RNAs encoded by LR were identified which contained putative viral micro RNAs that 
reduced bICP0 protein levels, but not steady-state levels of bICP0 RNA (Jaber et al., 
2010).  Inhibition of bICP0 subsequently extinguishes lytic viral gene expression.   
Expression of LR and ORF-E is important not only for establishing, but also 
maintaining latency and allowing persistence of the viral genome in sensory neurons 
(Jones, 1998; Jones, 2003).  Expression of LR proteins is necessary for inhibition of cell 
growth (Schang et al., 1996), apoptosis (Ciacci-Zanella et al., 1999; Henderson et al., 
2004a), and infiltration of inflammatory cells to sites of latently infected neurons (Perez 
et al., 2006).  ORF-E expression induces neurite-like outgrowth in murine neuroblastoma 
cells which suggests it may promote normal neuronal functions of latently infected cells 
(Perez et al., 2007).  An LR mutant virus was able to grow to similar titers as wt BHV-1 
in culture, but exhibited reduced clinical symptoms and viral shedding in cattle (Inman et 
al., 2001a; Inman et al., 2002; Perez et al., 2005).  In addition, the LR mutant was unable 
to reactivate from latency in infected calves, suggesting expression of LR gene products 
is not critical for productive infection, but is required for reactivation (Inman et al., 2002; 
Jones, 2003; Jones and Chowdhury, 2007; Perez et al., 2005).   
Stress-induced factors and immune suppression can lead to reactivation from 
latency.  Upon reactivation, expression of LR and ORF-E genes is significantly reduced, 
lytic gene expression proceeds and infectious virions are produced (Jones, 1998; Jones, 
2003; Jones and Chowdhury, 2007).  Treatment with glucocorticoids or the synthetic 
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corticosteroid dexamethasone (DEX) can induce reactivation and is used for investigative 
studies in cattle (Inman et al., 2002; Rock et al., 1992).  DEX treatment was shown to 
activate the bICP0 early promoter, and expression of bICP0 subsequently resulted in 
reactivation from latency (Workman et al., 2009).  Furthermore, a bICP0 mutant BHV-1 
strain able to establish latency, failed to reactivate in calves following treatment with 
DEX (Saira et al., 2008).  In summary, the LR gene and bICP0 are critical regulators of 
the latency-reactivation cycle. 
 
III.  BHV-1 encoded bICP0 
A. bICP0 mutant viruses 
bICP0 plays a pivotal role during the BHV-1 infection cycle.  bICP0 is not 
absolutely required for viral replication; however, it is critical for efficient viral growth 
and propagation.  Transfection of BHV-1 genomic DNA into permissive cells results in 
inefficient, basal level of viral replication and formation of plagues.  Co-expression of 
BHV-1 DNA and bICP0 significantly enhances viral replication and plaque formation, 
indicating bICP0 stimulates productive infection (Geiser and Jones, 2003; Inman et al., 
2001b).  bICP0-null or mutant viruses have reduced growth potential and are not stable.  
A BHV-1 recombinant virus that does not express the bICP0 protein (bICP0-null virus) 
does not produce plaques, yields reduced viral titers by at least 100 fold, and establishes a 
persistent-like infection in bovine cells (Geiser et al., 2005).  Furthermore, the bICP0-null 
virus was replication-deficient in calves (Geiser et al., 2005).  Another BHV-1 
recombinant virus (51G) containing a single mutation within the C3HC4 zinc RING 
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finger, an important functional domain of bICP0, was able to induce plaques, but grew 
poorly compared to the rescued virus or wt BHV-1 (Saira et al., 2008).  The 51G mutant 
also exhibited reduced growth kinetics, virulence, and was unable to reactivate from 
latency in infected calves (Saira et al., 2008).  Collectively, these studies demonstrate that 
expression of the bICP0 protein is critical for BHV-1 growth in cultured cells and 
productive infection in the host. 
 
B. Transcriptional activation 
bICP0 stimulates productive infection by acting as a potent transcriptional 
activator of all three classes of viral genes; however, it is does not appear to be a DNA-
binding protein (Wirth et al., 1992).  Instead, bICP0 appears to interact with other 
transcriptional regulators in order to stimulate viral gene expression.  bICP0 has been 
shown to promote activation of viral transcription in part by associating with chromatin 
remodeling enzymes.  bICP0 interacts with histone deacetylase 1 (HDAC1) and this 
interaction leads to relief of transcriptional repression mediated by HDAC1 (Zhang and 
Jones, 2001).  bICP0 also associates with the transcriptional co-activator p300, which 
possesses intrinsic histone acetyltransferase (HAT) activity (Zhang et al., 2006).  Over-
expression of p300 trans-activated a late viral promoter (gC) and enhanced  productive 
infection (Zhang et al., 2006).   
HATs and HDACs are key factors of transcriptional regulation because they 
modulate histones which are important components involved in packaging DNA into 
chromatin (Hassig and Schreiber, 1997; Kiermaier and Eilers, 1997; Struhl, 1998; Wade 
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and Wolffe, 1997; Wolffe, 1996).  HATs promote transcription by acetylating histone 
tails which destabilizes the chromatin structure allowing transcription machinery to gain 
access to promoter sequences for gene expression.  HDACs remove acetyl groups from 
histones returning chromatin to its tightly packaged structure and thereby repress 
transcription.  Thus, the ability of bICP0 to interact with these types of chromatin 
remodeling enzymes and other putative transcriptional regulators plays a critical role in 
the ability of bICP0 to stimulate viral gene expression. 
Several domains have been identified that are important for transcriptional 
activation by bICP0 (Figure 1B).  An intact zinc RING finger motif was not required for 
bICP0 to interact with either HDAC1 or p300 (Zhang et al., 2006; Zhang and Jones, 
2001); however, mutagenesis of the zinc RING finger did affect the ability of bICP0 to 
activate viral transcription (Zhang et al., 2006; Zhang and Jones, 2001).  In addition to 
the zinc RING finger motif, two major transcriptional activation domains (TADs) have 
been identified which consist of the region between amino acids 78 and 256, and C-
terminal residues at or near amino acid 457 of the bICP0 protein (Zhang et al., 2005).  
bICP0 also contains an acidic region which can be found in many transcriptional 
activators (Zhang et al., 2005).  To date, it has not been shown to play a role in activating 
transcription (Zhang et al., 2005).  Further studies are required to understand the 
complete molecular mechanism of transcriptional activation by bICP0 and the role of 
TAD residues for this activity. 
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C. Interferon inhibition 
In addition to its ability to stimulate productive infection, bICP0 is able to 
regulate the interferon (IFN) response.  IFN- is part of the type I IFN response pathway 
that plays a pivotal role in amplification of innate immunity and antiviral defense (Katze 
et al., 2002; Randall and Goodbourn, 2008).  bICP0 inhibits IFN- transcriptional 
activation by affecting at least three major regulators of IFN- expression:  IRF3, IRF7, 
and p300 (Saira et al., 2007; Saira et al., 2009; Zhang et al., 2006).  IRF3 and IRF7 are 
key components of the IFN response pathway because they act as co-activators of the 
IFN- promoter (Hiscott, 2007).  p300 is a co-activator of the IRF3-dependent IFN 
signaling pathway and other antiviral signaling cascades (Hiscott, 2007; Vo and 
Goodman, 2001; Weaver et al., 1998; Yoneyama et al., 1998).  Upon viral recognition by 
innate immune sensors, IRF3 and IRF7 become activated through phosphorylation events 
and are translocated to the nucleus.  In the nucleus, IRF3 and IRF7 associate with other 
co-activators including p300 to induce IFN- gene expression.  bICP0  inhibits IFN- 
promoter activity by inducing proteasome-dependent degradation of IRF3 (Saira et al., 
2007).  In addition, bICP0 associates with IRF7 and this interaction also inhibits 
activation of the IFN- promoter (Saira et al., 2009).  The interaction between bICP0 and 
p300 may also interfere with p300-stimulated antiviral signaling (Zhang et al., 2006). 
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D. E3 ligase activity 
Several functional domains of bICP0 have been identified, including a nuclear 
localization signal (NLS) located at its C-terminus, two transcriptional activation 
domains (TADs) separated by an acidic region, and a C3HC4 zinc RING finger motif 
(Figure 1B).  The zinc RING finger domain located at the N-terminus contains seven 
conserved cysteine residues from the 13
th
 to the 51
st
 amino acid of the bICP0 protein.  
The zinc RING finger motif is conserved among Alphaherpesvirinae ICP0 homologues 
and plays a critical role in the biological functions of bICP0 (Everett et al., 2010).  The 
C3HC4 zinc RING finger motif possesses intrinsic E3 ubiquitin ligase activity and the 
ICP0-related proteins encoded by HSV-1, VZV, EHV-1, PRV and BHV-1 were all 
shown to be active E3 ligases in vitro (Everett et al., 2010).  E3 ubiquitin ligases can be 
divided into HECT- or really interesting novel gene (RING)-containing proteins, and 
proteins containing a zinc RING finger motif make up the largest class of potential E3 
ubiquitin ligases (Deshaies, 2005a; Deshaies, 2005b; Pickart, 2001).  E3 ubiquitin ligases 
are diverse and provide the specificity by which proteins are modified by ubiquitin (Nagy 
and Dikic, 2010; Pickart, 2001).   
ICP0 is an established E3 ubiquitin ligase (Boutell et al., 2002; Hagglund and 
Roizman, 2002; Van Sant et al., 2001) that induces the ubiquitin mediated degradation of 
a number of proteins (Boutell and Everett, 2003; Chelbi-Alix and de The, 1999; Everett 
et al., 1999a; Everett et al., 1998; Fukuyo et al., 2011; Lomonte and Morency, 2007; 
Lomonte et al., 2001; Parkinson et al., 1999).  bICP0 has also been shown to induce 
polyubiquitination and proteosome-dependent degradation of certain cellular proteins.  
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bICP0 directly catalyzes the ubiquitination of IB in order to activate the NF-B 
signaling pathway (Diao et al., 2005), and reduces IRF3 protein levels in a proteasome-
dependent manner (Saira et al., 2007).  An intact zinc RING finger and sequences near 
the C-terminus were required for bICP0-mediated IRF3 proteolysis (Saira et al., 2007).  
Studies designed to identify targets of bICP0 for ubiquitination are discussed in Chapter 
2, and the effect of bICP0 on cellular promyelocytic leukemia (PML) protein is examined 
in Chapter 3 of this dissertation. 
 
E. Cytotoxicity of bICP0 
Herpesviruses are cytolytic and their infection causes cytopathic effect.  BHV-1 
infection of calves or of cultured cells is known to lead to apoptosis (Devireddy and 
Jones, 1999a; Lovato et al., 2003; Winkler et al., 2000).  Interestingly, transient 
expression of bICP0 is toxic to transfected cells (Inman et al., 2001b).  bICP0 can induce 
cleavage of caspase 3 which leads to activation of the apoptotic pathway (Henderson et 
al., 2004b).  Compared to a pro-apoptotic factor (Bax), bICP0 induced caspase 3 cleavage 
at later times after infection, suggesting the ability of bICP0 to activate caspase 3 is by an 
indirect mechanism (Henderson et al., 2004b).  Mutations within the zinc RING finger 
motif of bICP0 reduced toxicity associated with expression of bICP0 (Henderson et al., 
2004b).  A bICP0 mutant lacking amino acids from 356 to 676 of the C-terminus of the 
bICP0 gene (referred to in the literature as bICP0 or C-terminus) localizes primarily to 
the cytoplasm and was more efficient at activating caspase 3 cleavage than wt bICP0 
(Henderson et al., 2004b; Inman et al., 2001b), suggesting that interactions of bICP0 with 
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cytoplasmic factors could enhance cytotoxicity and apoptosis.  Although, induction of 
apoptosis is usually believed to negatively regulate and control virus infection, there are 
examples to the contrary.  For example, caspase 3 has been shown to enhance HSV-1 
reactivation from latency (Hunsperger and Wilcox, 2003).  The fact that bICP0 is critical 
for reactivation in cattle, suggests that the ability of bICP0 to activate caspase 3 may play 
a role in stimulating reactivation from latency and productive infection (Henderson et al., 
2004b; Jones, 2003). 
 
F. Localization of bICP0 
bICP0 contains a basic NLS-like motif (KRRR) that is located between amino 
acids 622 and 625 at the C-terminus of the protein (Zhang et al., 2005).  Deletion of 
fragments near the C-terminus including the NLS domain, result in an accumulation of 
bICP0 in the cytoplasm (Inman et al., 2001b; Zhang et al., 2005).  During productive 
infection or in transiently transfected cells, bICP0 can be found at PML protein-
containing subnuclear domains (Gaudreault and Jones, 2011; Inman et al., 2001b; 
Parkinson and Everett, 2000).  A zinc RING finger mutant is also observed to localize to 
foci within the nucleus, however, its pattern is distinct from wt bICP0 (Inman et al., 
2001b).  In general, wt bICP0 can be found diffusely throughout the nucleus, or localized 
discretely to PML nuclear domains or nucleoli-like structures in infected or transiently 
transfected cells.  Conversely, the zinc RING finger mutant primarily has a consistent 
punctate nuclear appearance, suggesting certain zinc RING finger-dependent 
modifications or interactions with other proteins may influence bICP0 localization.  
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bICP0 can also be found in the cytoplasm of low passage bovine cells at later times of 
BHV-1 infection (Gaudreault and Jones, 2011).  This implicates a role for cytoplasmic 
bICP0 during infection, and suggests late viral proteins or induced factors may sequester 
bICP0 to the cytoplasm.  Recently, bICP0 localized to the cytoplasm was shown to 
inhibit IFN- promoter activity and induce degradation of IRF3 as efficiently as wt 
bICP0 (Da Silva and Gaudreault, unpublished).  Thus, this data suggests a role for 
cytoplasmic bICP0 in repressing the innate immune response after infection.   
 
IV.  Cellular PML and viral infection 
A. PML nuclear bodies 
The PML protein is an essential component of PML bodies, also referred to as 
nuclear domain 10 (ND10), PML oncogenic domains (PODs), or Kruppel bodies, which 
are distinct nuclear structures that have a punctate appearance when examined by 
fluorescent microscopy (Lallemand-Breitenbach and de The, 2010).  The size and 
number of these nuclear foci depend on the cellular context, but in general, they range 
from 1 to 30 structures with a diameter of approximately 0.2 to 1 m (Dellaire and 
Bazett-Jones, 2004).  The presence of the PML protein is essential for the formation of 
these unique domains and for recruitment of other proteins (Ishov et al., 1999; Zhong et 
al., 2000).  Constitutive components of PML bodies include Sp100, DAXX, and SUMO 
(small ubiquitin-like modifier) (Negorev and Maul, 2001).  Cell cycle, cellular stress, 
DNA damage, and other extrinsic factors can influence the composition of PML nuclear 
bodies (Dellaire and Bazett-Jones, 2004; Everett et al., 1999b; Maul et al., 2000).  A 
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growing number of more than 160 proteins involved in a variety of cellular activities are 
known to traffic to and from PML nuclear domains (Lallemand-Breitenbach and de The, 
2010; Van Damme et al., 2010).  A common feature among proteins recruited to PML 
bodies is their ability to be SUMOylated (Bernardi and Pandolfi, 2007; Van Damme et 
al., 2010).  PML bodies have been linked to such responses as DNA damage, stress, 
senescence, apoptosis, protein degradation, interferon, and viral infection (Bernardi and 
Pandolfi, 2003; Everett and Chelbi-Alix, 2007; Geoffroy and Chelbi-Alix, 2011; 
Lallemand-Breitenbach et al., 2001; Regad and Chelbi-Alix, 2001; Tavalai and 
Stamminger, 2008).  However, the underlying function of these distinct subnuclear 
structures is still not clearly understood and elucidation is complicated by their dynamic 
nature.  A current model proposed is that PML acts as the glue which brings protein 
partners together at PML bodies to enhance post-translational modifications and thus 
yield activation, sequestration, or degradation of proteins (Lallemand-Breitenbach and de 
The, 2010).   
 
B. The PML protein 
The PML gene was first identified 20 years ago as the fusion partner with the 
retinoic acid receptor alpha (RARa) gene due to a translocation between chromosomes 15 
and 17 found in patients with acute promyelocytic leukemia (APL) (de The et al., 1990; 
de The et al., 1991).  PML is expressed in most cells of normal tissues and can also be 
found in tumors of various origins; however, loss of PML expression correlates with 
tumor progression (Gurrieri et al., 2004).  PML knockout mice are viable, but are prone 
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to develop tumors and more susceptible to infections (Wang et al., 1998a; Wang et al., 
1998b).  Overexpression of PML can inhibit tumor formation in nude mice (Mu et al., 
1994) and the replication of several viruses (Blondel et al., 2002; Bonilla et al., 2002).  
The human PML gene contains 9 exons and generates multiple isoforms due to 
alternative splicing designated as PML I-VII that differ in their C-termini (Jensen et al., 
2001).  PML expression is dependent on cell type and the stage of differentiation (Cho et 
al., 1998; Flenghi et al., 1995), as well as extrinsic factors such as infections and stress-
induced responses (Maul et al., 2000).  IFN, IRF3, and the tumor suppressor p53 have all 
been found to induce PML expression through distinct mechanisms (Ferbeyre et al., 
2000; Kim et al., 2007; Stadler et al., 1995).  Splice variants of PML differ by their 
expression level, have unique subcellular and subnuclear localizations, and are implicated 
in having distinct functions in a variety of cellular processes (Condemine et al., 2006).   
PML undergoes extensive post-translational modifications which regulate the 
stability, localization, and activity of the protein (Nichol et al., 2009; Reineke and Kao, 
2009).  Modification of PML by SUMO is the most characterized and appears to be 
important for PML regulation at several levels (Lallemand-Breitenbach et al., 2001; 
Nichol et al., 2009).  SUMO-modification of PML is required for the formation of 
nuclear body structures, maintaining their integrity, and recruiting other proteins 
(Bernardi and Pandolfi, 2007; Evdokimov et al., 2008; Nacerddine et al., 2005; Zhong et 
al., 2000).  SUMOylation regulates arsenic-induced PML ubiquitination which leads to 
PML degradation (Tatham et al., 2008).  Phosphorylation of PML appears to be required 
for modifications by SUMO, but is able to regulate PML activity independently of 
SUMOylation (Hayakawa and Privalsky, 2004).  Acetylation of PML is implicated to 
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play a role in the PML-dependent apoptotic pathway (Hayakawa et al., 2008).  PML is 
also reported to be modified by interferon-stimulated gene 15 (ISG15) another small 
ubiquitin-like peptide (Shah et al., 2008) which is conjugated to proteins following 
stimulation by type 1 interferons, and infection by viruses or bacteria (Welchman et al., 
2005).   
Most PML isoforms contain a common NLS at their C-terminus and are localized 
to the nucleus.  However, PML is also known to be expressed in the cytoplasm either 
because of loss of the NLS due to alternative splicing or recruitment by other proteins 
(Condemine et al., 2006; Lin et al., 2004a).  Cytoplasmic PML has been shown to be 
important for regulating apoptosis and in resistance to viral infection (Giorgi et al., 2010; 
McNally et al., 2008).  Although the effect of PML on various cellular processes and 
response pathways has been documented {Reviewed in (Bernardi and Pandolfi, 2003; 
Lallemand-Breitenbach and de The, 2010; Pearson and Pelicci, 2001; Salomoni and 
Pandolfi, 2002)}, the underlying molecular mechanisms remain greatly unknown, and no 
unifying principle for the physiological effects of PML has been discovered (Culjkovic-
Kraljacic and Borden, 2010).   
 
C. Viral interactions with PML 
It is well established that infection by a wide variety of viruses affects PML and 
PML-containing nuclear bodies [Reviewed in (Everett and Chelbi-Alix, 2007; Geoffroy 
and Chelbi-Alix, 2011; Tavalai and Stamminger, 2008)].  A number of viruses target 
PML in order to promote viral replication and encode proteins that are able to regulate 
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PML by a variety of mechanisms.  A summary of DNA and RNA viruses and their 
encoded proteins that are known to colocalize with PML and disrupt PML body 
organization are listed in Table 1.  Several of these viral proteins induce PML 
degradation, and reduction of PML correlates with increased viral replication efficiency.  
For example, lymphocytic choriomeningitis virus (LCMV), vesicular stomatitis virus 
(VSV), rabies, and encephalomyocarditis virus (EMCV) have increased replication 
efficiency in PML knockout mice (Bonilla et al., 2002), or cells derived from PML 
knockout mice (Blondel et al., 2002; Djavani et al., 2001; El McHichi et al., 2010).  
Overexpression of PML also correlates with repression of replication of rabies virus, 
LCMV and VSV (Blondel et al., 2002; Bonilla et al., 2002).  In contrast, replication of 
HSV-1 and human foamy virus (HFV) was not shown to be affected by knockdown of 
endogenous PML; however, in the absence of PML these viruses were less sensitive to 
IFN (Chee et al., 2003; Regad and Chelbi-Alix, 2001).  These studies are in support of 
growing evidence that implicates PML as a mediator of IFN-induced antiviral response 
(Everett and Chelbi-Alix, 2007; Regad and Chelbi-Alix, 2001).  PML belongs to the 
TRIM (TRIpartite Motif) family of proteins (Jensen et al., 2001).  The TRIM proteins 
contain RBCC motif which consists of a RING-finger, two B-boxes, and an alpha-helical 
Coiled-Coil domain.  These proteins are emerging as important players in IFN responses 
and antiviral defense (Ozato et al., 2008).  Furthermore, PML isoforms I-IV and VI have 
been shown to independently have antiviral activity (Blondel et al., 2010; Chelbi-Alix et 
al., 1998; Cuchet et al., 2011; Doucas and Evans, 1996; Iki et al., 2005; Pampin et al., 
2006). 
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The ICP0-related proteins of Alphaherpesvirinae members are known to interact 
with PML bodies.  The proteins encoded by HSV-1, VZV, EHV-1, PRV, and BHV-1 
(ICP0, ORF61P, EICP0, EP0 and bICP0, respectively) have been observed to affect PML 
bodies with varying outcomes (Everett et al., 2010; Kyratsous and Silverstein, 2009; 
Parkinson and Everett, 2000; Reichelt et al., 2009).  HSV-1 encoded ICP0 was the first 
viral protein reported to modify PML nuclear structures and has been the most widely 
studied (Everett and Chelbi-Alix, 2007; Everett and Maul, 1994; Geoffroy and Chelbi-
Alix, 2011; Maul et al., 1993).  ICP0 disrupts PML bodies by inducing proteasome-
dependent degradation of the PML and Sp100 proteins (Chelbi-Alix and de The, 1999; 
Everett et al., 1998).  This effect of ICP0 correlates with increased viral gene expression 
and replication (Everett and Maul, 1994; Everett et al., 2008; Everett et al., 2006).  In 
addition to HSV-1 ICP0, EHV-1 and PRV encoded ICP0-like proteins are able to cause 
changes in the abundance of certain SUMO-modified PML isoforms (Everett et al., 
2010).  Conversely, VZV encoded ORF61P does not appear to significantly alter PML 
and Sp100 protein levels; however, depletion of PML did enhance viral replication 
(Kyratsous and Silverstein, 2009).  There is recent evidence that endogenous PML can 
form nuclear cages that entrap VZV nucleocapsids in the nucleus and consequently 
inhibit formation of infectious viral particles (Reichelt et al., 2011).  PML IV was 
identified as the isoform responsible for sequestering VZV nucleocapsids to these nuclear 
PML cages (Reichelt et al., 2011).  This distinct group of PML nuclear bodies appears to 
safely contain aggregation-prone aberrant proteins and viral capsids and thus contributes 
to the intrinsic antiviral host response against VZV (Reichelt et al., 2011).  Although 
BHV-1 encoded bICP0 is known to localize to and disorganize PML nuclear bodies, 
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previous studies have failed to show that bICP0 affects PML steady state levels (Everett 
et al., 2010; Inman et al., 2001b; Parkinson and Everett, 2000).  Studies investigating the 
regulation of PML by bICP0 are examined in Chapter 3 of this dissertation. 
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FIGURE 1 
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Figure 1.  Map of the BHV-1 genome, location of bICP0 transcripts, and domains of 
the bICP0 protein. 
Panel A:  Schematic of the bICP0 gene within the BHV-1 genome and the position of 
transcripts encoded by immediate early transcription unit (IEtu1) and IEtu2.  The Unique 
Long (L) and Unique Short (S) regions of the BHV-1 genome are indicated.  IEtu1 
encodes bICP4 (IE/4.2) and bICP0 (IE/2.9) and these immediate early (IE) transcripts are 
under the control of the IEtu1 promoter.  The E/2.6 early transcript encodes bICP0 under 
the control of the early (E) promoter.  IEtu2 encodes bICP22 in the opposite orientation 
to IEtu1.  Exons (e) are illustrated by solid lines and the spliced intron sequences depicted 
by the dashed lines.  The origin of replication (ORI) is denoted.  The latency related (LR) 
transcript which partially overlaps bICP0 in the opposite orientation is also shown.   
Panel B:  Schematic of the bICP0 protein and its known functional domains.  The 
functional domains include a nuclear localization signal (NLS) at the C-terminus, two 
transcriptional activation domains (TAD), an acidic domain, and the C3HC4 zinc RING 
finger at the N-terminus.  The amino acid sequence (13-51) of the zinc RING finger 
domain is shown and the 7 highly conserved cysteine residues are highlighted in bold 
text.   
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Table 1.  The affects of viral encoded proteins on PML nuclear bodies 
Virus Viral 
protein 
Affect on PML References 
DNA viruses    
HSV-1 ICP0 Induces proteasome-
dependent degradation of 
PML and disrupts PML 
NBs 
(Everett et al., 1998; 
Everett and Maul, 1994; 
Maul et al., 1993) 
KSHV LANA-2 Disrupts PML NBs (Marcos-Villar et al., 
2009) 
HCMV IE1 Disrupts PML NBs (Ahn and Hayward, 1997) 
EBV BZLF Disrupts PML NBs (Adamson and Kenney, 
2001) 
HPV E6 Induces proteasome-
dependent degradation of 
PML 
(Louria-Hayon et al., 
2009) 
Adenovirus E4Orf3, 
E1B-55 K 
Disrupts PML NBs (Doucas and Evans, 1996) 
RNA viruses    
HCV core Interacts with PML IV and 
inhibits PML IV-induced 
apoptosis 
(Herzer et al., 2005) 
HDV L-HDAg Alters PML NB structures 
and distribution of 
associated proteins 
(Bell et al., 2000) 
LCMV Z Interacts with PML and 
reorganizes PML NBs 
(Borden et al., 1998) 
Rabies P Interacts with PML and 
reorganizes PML NBs 
(Blondel et al., 2002) 
EMCV 3Cpro Induces proteasome- and 
SUMO-dependent 
degradation of PML 
(El McHichi et al., 2010) 
HSV-1, herpes simplex virus 1; KSHV, Karposi’s sarcoma-related herpesvirus; HCMV, human 
cytomegalovirus; EBV, Epstein Barr virus; HPV, human papillomavirus; HCV, hepatitis C virus; HDV, 
hepatitis delta virus; LCMV, lymphocytic choriomeningitis virus; EMCV, encephalomyocarditis virus. 
{Table adapted from (Geoffroy and Chelbi-Alix, 2011)} 
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CHAPTER 2 
 
The zinc RING finger domain of bICP0 regulates protein ubiquitination and 
stability of the bICP0 protein. 
 
Part of the studies presented in this chapter was included in a previous publication: 
Kazima Saira, Shafiqul Chowdhury, Natasha Gaudreault, Leticia da Silva, Gail 
Henderson, Alan Doster, and Clinton Jones (2008).  The zinc RING finger of bovine 
herpesvirus 1-encoded bICP0 protein is crucial for viral replication and virulence.  J Virol  
82:  12060-12068. 
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ABSTRACT 
Bovine herpesvirus 1 (BHV-1) encoded infected cell protein 0 (bICP0) contains a 
C3HC4 zinc RING (really interesting novel gene) finger motif that possesses intrinsic E3 
ubiquitin ligase activity and is critical for its functions.  The zinc RING finger domain is 
conserved among alphaherpesvirinae bICP0 homologues and is important for efficient 
polyubiquitination and degradation of certain cellular proteins.  Studies with herpes 
simplex virus have demonstrated the zinc RING finger motif is also important for the 
stability of the ICP0 protein itself due to regulation by autoubiquitination.  In this study, 
we examined what effect transiently expressed bICP0 had on the polyubiquitination of 
cellular proteins and attempted to identify novel proteins targeted by bICP0 for 
degradation.  In addition, we examined what effect the zinc RING finger domain had on 
the stability of bICP0 in transiently transfected or productively infected cells.  These 
studies provide further evidence that bICP0 is a functioning E3 ubiquitin ligase and 
suggest that this activity may be important for regulating bICP0 protein levels during 
productive infection. 
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INTRODUCTION 
Ubiquitin-dependent proteolysis is a critical process for regulating cellular protein 
levels in order to maintain homeostatic cellular conditions (Hochstrasser, 1995).  
Ubiquitination is a post-translational modification event that generally targets proteins for 
degradation by the 26S proteosome (Sorokin et al., 2009).  Ubiquitin-protein conjugation 
involves three families of enzymes.  The highly conserved ubiquitin enzymes 1 (E1) and 
E2 are responsible for recruiting ubiquitin and catalyzing the initial steps of the pathway 
(Schulman and Harper, 2009; van Wijk and Timmers, 2010).  The third family of 
enzymes in this pathway is the E3 ligases which catalyze the final step of the ubiquitin 
conjugation reaction.  E3 ubiquitin ligases are diverse and provide the specificity by 
which proteins are ubiquitin modified (Nagy and Dikic, 2010; Pickart, 2001).  Proteins 
containing a zinc RING finger motif make up the largest class of potential E3 ubiquitin 
ligases (Deshaies, 2005a).   
BHV-1 bICP0 is a C3HC4 zinc RING containing multifunctional viral protein that 
is critical for viral replication and virulence (Saira et al., 2008).  An intact zinc RING 
finger domain is required for many of bICP0’s functions (Jones, 2009), including its 
ability to efficiently induce polyubiquitination and proteosome-dependent degradation of 
certain cellular proteins.  bICP0 has been shown to directly catalyze polyubiquitination of 
IB in order to activate the NF-B signaling pathway (Diao et al., 2005).  In addition, 
bICP0 reduced protein levels of interferon regulatory factor 3 (IRF3) and promyelocytic 
leukemia protein (PML) (Gaudreault and Jones, 2011; Saira et al., 2007).  Inhibition of 
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the proteosome interfered with bICP0 induced reduction of these proteins suggesting that 
proteolysis was ubiquitin mediated.   
Viruses utilize ubiquitin-dependent proteolysis to influence both cellular and viral 
protein levels (Gao and Luo, 2006).  Herpes simplex virus 1 (HSV-1) encoded infected 
cell protein 0 (ICP0) is an established E3 ubiquitin ligase (Boutell et al., 2002; Hagglund 
and Roizman, 2002; Van Sant et al., 2001) that induces the ubiquitin mediated 
degradation of a number of proteins (Boutell and Everett, 2003; Chelbi-Alix and de The, 
1999; Everett et al., 1999a; Everett et al., 1998; Fukuyo et al., 2011; Lomonte and 
Morency, 2007; Lomonte et al., 2001; Parkinson et al., 1999).  It is known that HSV-1 
ICP0 also regulates its own expression by self-ubiquitination, and that zinc RING finger 
mutants are more stable due to their disabled E3 ligase activity (Boutell et al., 2002; 
Canning et al., 2004; Everett et al., 1995).  The C3HC4 zinc RING finger is a conserved 
functional domain among Alphaherpesvirinae subfamily member ICP0 homologues, 
including BHV-1 encoded bICP0.  Consequently, we hypothesize that bICP0 functions as 
an E3 ubiquitin ligase to induce ubiquitination of proteins and that it may also regulate its 
own expression levels by autoubiquitination.   
bICP0 is a multifunctional protein that plays a pivotal role in the BHV-1 
infectious cycle (Jones, 2009).  Identifying novel ubiquitinated proteins targeted for 
degradation by bICP0 would provide insight to the functions and the underlying 
mechanisms of bICP0 during productive infection.  We therefore compared the global 
level of ubiquitinated proteins in cells expressing wt bICP0 or a zinc RING finger 
mutant, and examined the protein stability of bICP0 in cells infected with a wt BHV-1 
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strain or a zinc RING finger mutant virus.  We predicted that mutation of the bICP0 zinc 
RING finger domain would hinder its E3 ligase activity, and as a result affect its ability 
to induce ubiquitination of proteins and to regulate its own half-life.  This study 
demonstrates that the zinc RING finger domain plays an important role in bICP0’s ability 
to induce protein ubiquitination, and as a result influences its own stability. 
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MATERIALS AND METHODS 
 
Cells and viruses 
Bovine kidney (CRIB) cells and murine neuro-2A cells were grown in Earle’s 
modified Eagle’s medium supplemented with 10% fetal calf serum and penicillin (10 
U/ml) and streptomycin (100 ug/ml) in a humidified 5% CO2 chamber at 37 C.  CRIB 
cells, derived from MDBK cells, are resistant to infection with bovine viral diarrhea virus 
and were obtained from Ruben Donis (Centers for Disease Control and Prevention, 
Atlanta, GA).   
The wt BHV-1 Cooper strain was obtained from the National Veterinary Services 
Laboratory, Animal and Plant Health Inspection Services (Ames, IA).  Construction of 
the BHV-1 bICP0 zinc RING finger domain mutant (51g) and the rescue virus (51gR) 
was described previously (Saira et al., 2008).  BHV-1 strains were propagated and titrated 
in CRIB cells.  For infection studies, cells were plated onto 60 or 100 mm culture dishes 
16 to 24 hours prior to virus infection.  Total cells per plate were counted and the 
multiplicity of infection (MOI) calculated.  Cells were infected with the wt BHV-1, 51g, 
or 51gR at an MOI of 1.0, and were harvested at the indicated times after infection. 
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Expression plasmids 
The wild type and mutated bICP0 plasmids are cloned into a pCMV2 expression 
vector downstream of a Flag tag and under the control of the human cytomegalovirus 
(CMV) promoter.  The zinc RING finger mutant 13G/51A contains point mutations 
within two conserved amino acids of the C3CH4 zinc RING finger (Inman et al., 2001b).  
The ubiquitin plasmid contains a hemagglutinin tag (HA-Ub).  For transfections, 
TransitIT-LT1 reagent (MIR 2300, Mirus) was used according to the manufacturer’s 
protocol.  Empty vector was used as a fill to ensure equal amounts of total DNA were 
introduced into the cells. 
 
Western blot analysis 
Cells were harvested at the indicated times after infection.  Cells were washed 
with PBS and suspended in cell lysis buffer (100 mM Tris, pH 8.0, 1mM EDTA, 100 mM 
Na Cl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride) and one tablet of complete 
protease inhibitor (Roche Molecular Biochemicals) per 10 ml of buffer.  The cell 
suspension was sonicated and incubated at 4°C for 20 min, then centrifuged at 13,000 
rpm at 4°C for 15 min.  Protein concentrations were then determined by the Bradford 
assay (Bio-Rad), and the lysate was boiled in SDS-PAGE buffer.  After electrophoresis, 
proteins were transferred to a polyvinylidene difluoride membrane (Immobilon-P; 
Millipore).  Membranes were blocked in Tris-buffered saline that contained 5% milk.  
The ubiquitin (sc-9133), HA (sc-805), and beta-actin (sc-1616) antibodies were 
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purchased from Santa Cruz Biotechnology.  Expression of the bICP0 protein was 
detected using a polyclonal anti-bICP0 peptide antibody that was produced in rabbits.  
Membranes were then incubated overnight with the indicated primary antibody in 5% 
milk-containing 0.1% Tween 20–Tris-buffered saline.  After washing with 0.1% Tween 
20–Tris-buffered saline, membranes were incubated with donkey anti-goat (sc-2020; 
Santa Cruz Biotechnology) or donkey anti-rabbit (NA934V, Amersham Biosciences) 
horseradish peroxidase-conjugated immunoglobulin G secondary antibodies diluted in 
blocking buffer.  Immunodetection was performed with enhanced chemiluminescence 
western blotting detection reagents (Perkin-Elmer, MA) in accordance with the 
manufacturer’s protocol.  All figures are representative of three or more independent 
experiments.  
 
Ubiquitin Enrichment Assay 
For several experiments we used the Ubiquitin Enrichment Kit (Pierce 89899) to 
isolate intracellular polyubiquitin-modified proteins through the use of a high-binding 
affinity resin provided by the kit.  Cell extracts were collected as described, protein 
concentrations measured and equal amounts used for ubiquitin enrichment according to 
the manufacturer’s protocol.  Extracts collected after enrichment were then subjected to 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and western 
blot analysis. 
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RESULTS 
 
bICP0 induces ubiquitination of cellular proteins. 
The C3HC4 zinc RING finger domain located in bICP0 possesses intrinsic E3 
ubiquitin ligase activity (Diao et al., 2005), and previous studies have demonstrated 
bICP0 is able to induce the proteasome-dependent degradation of specific proteins 
(Gaudreault and Jones, 2011; Saira et al., 2007).  We therefore attempted to identify 
novel proteins targeted for polyubiquitination and consequently proteolysis by bICP0.  
Ubiquitination of cellular proteins was examined following co-transfection of 2A cells 
with a hemagglutinin-tagged ubiquitin (HA-Ub) plasmid and bICP0, 13G51A, or empty 
expression vector.  Cells were collected and lysed 48 hours post-transfection and 
analyzed by western blot with anti-HA antibody.  As expected, over-expression of 
ubiquitin resulted in a ladder of ubiquitinated proteins that resemble a smear (Figure 1).  
Increased accumulation of ubiquitinated proteins in cells expressing bICP0 was 
consistently observed (Figure 1, lane 2) suggesting bICP0 was a functionally active E3 
ubiquitin ligase that increased protein ubiquitination.  However, we were unable to 
consistently detect unique ubiquitinated bands in cells transfected with wt bICP0.  A 
bICP0 mutant containing substitutions of two critical cysteine residues of the zinc RING 
finger domain (13g51a) was also tested.  Cells expressing the 13g51a mutant consistently 
produced lower levels of ubiquitinated proteins than wt bICP0, and resulted in similar or 
less levels than empty vector expressing cells (Figure 1, lane 3).  In summary, these 
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studies suggest bICP0 was able to induce the ubiquitination of cellular proteins and that 
an intact zinc RING finger domain is important for this activity. 
 
Analysis of ubiquitinated proteins during productive infection. 
Ubiquitinated protein levels were examined in cells that were productively 
infected with wt BHV-1 or the 51g mutant virus.  The 51g mutant contains a single 
amino acid substitution that results in compromised growth in cultured cells, and reduces 
virulence in cattle (Saira et al., 2008).  Because this mutation is a disruption of the bICP0 
zinc RING finger domain, we predicted that the E3 ubiquitin ligase activity would also be 
impaired and ubiquitinated protein levels would be reduced compared to wt BHV-1 
infected cell levels.  CRIB cells were infected for 1 hour at 1 or 5 MOI.  The media was 
then replaced and lactacystin added to prevent proteosome-dependent degradation of 
proteins.  Cellular extracts were collected and ubiquitin levels analyzed by western blot 8 
hours post infection.  We were unable to consistently detect a significant difference 
between BHV-1 infected cells and mock (Figure 2, A), or the 51g mutant (Figure 2, B).   
 
Polyubiquitination of IRF3 induced by bICP0. 
Expression of bICP0 has been shown to reduce IRF3 protein levels in transiently 
transfected cells in a proteasome-dependent manner (Saira et al., 2007).  We therefore 
attempted to demonstrate polyubiquitination of IRF3 induced by bICP0 in transfected 
cultured cells.  In order to purify and evaluate only ubiquitin modified proteins we used 
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an ubiquitin enrichment kit purchased from Pierce which uses a high-affinity resin to 
isolate polyubiquitinated proteins from cell extracts.  Neuro-2A cells transfected with 
bICP0, IRF3, and/or HA-Ub were collected and analyzed by western blot with IRF3 or 
ubiquitin antibodies.  Cells were treated with lactacystin prior to collection in order to 
prevent proteasome-dependent degradation of proteins.  After ubiquitin enrichment, 
slightly higher levels of ubiquitinated IRF3 were detected in cells that expressed bICP0 
(Figure 3).  Polyubiquitinated proteins have an added mass of at least 32 kDa compared 
to the mass of a non-modified protein of interest.  Consistent with the above results, an 
increased accumulation of ubiquitinated proteins was observed in cells expressing bICP0 
following ubiquitin enrichment (data not shown).  These experiments provide further 
evidence that bICP0 is a functional E3 ubiquitin ligase. 
 
bICP0 protein levels during productive infection.   
bICP0 expression was examined following infection of CRIB cells with the 51g 
mutant or 51gR at an MOI of 1.  Cell lysate was collected at different times after 
infection, and Western analysis was performed with an anti-bICP0 peptide antibody.  
Higher levels of bICP0 protein expression were consistently observed following infection 
of bovine cells with the 51g mutant than following infection with 51gR or wt BHV-1 
(Figure 4 and data not shown).  Previous studies demonstrated that HSV-1 ICP0 mutants 
with reduced E3 ubiquitin ligase activity have increased stability as a result of decreased 
autoubiquitination (Boutell et al., 2005; Canning et al., 2004).  We predicted that the 
cysteine-to-glycine mutation in the 51
st
 amino acid of bICP0 disrupted the putative E3 
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ubiquitin ligase activity of bICP0 and, consequently, that the 51g mutant version of 
bICP0 would have a longer half-life.  To test this prediction, CRIB cells were infected 
with wt BHV-1, the 51gR strain, or the 51g mutant, and at 6 h after infection, cells were 
treated with 100 ug/ml cycloheximide treatment.  The bICP0 protein was readily detected 
after treatment with cycloheximide when cells were infected with the 51g mutant.  
Conversely, bICP0 was not readily detected in cells infected with wt BHV-1 or the 51gR 
strain after treatment with cycloheximide.  As expected, the bICP0-specifec antiserum 
did not recognize a protein in mock-infected cells.  Similar levels of beta-actin were 
present in each lane, confirming that similar protein levels were loaded for each sample 
(Figure 4, bottom).  In summary, these studies suggested that the 51g mutant bICP0 had 
increased stability during productive infection and was consequently expressed at higher 
levels.   
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DISCUSSION 
In this study, we provide evidence that bICP0 is an active E3 ubiquitin ligase, 
which is able to induce ubiquitination of proteins and regulate its own expression levels 
by self-ubiquitination.  We also attempted to demonstrate the ubiquitination of IRF3 
(Figure 3), a known protein targeted for degradation by bICP0 (Saira et al., 2007).  In 
cells expressing bICP0, we consistently observed slightly higher levels of ubiquitinated 
proteins (Figure 1).  More specifically, we also observed an increase in polyubiquitinated 
IRF3 in cells expressing bICP0.  Compared to transient transfection, productively 
infected cells expressing bICP0 generally appeared to have less of a significant effect on 
ubiquitinated protein levels (Figure 2).  This may be attributed to the expression level and 
half-life of bICP0 which is more abundant and stable in the absence of other viral 
proteins, suggesting bICP0 levels are regulated by other viral encoded or induced factors 
(Gaudreault and Jones, 2011).  Furthermore, we were not able to identify novel 
ubiquitinated targets in cells infected with BHV-1 or expressing bICP0. 
Transient-transfection assays and cell-free assays have indicated that the bICP0 
protein possesses E3 ubiquitin ligase activity which can induce ubiquitin dependent 
proteolysis of proteins and that the zinc RING finger is crucial for this activity (Diao et 
al., 2005).  The 51g mutation is predicted to disrupt the structure of the zinc RING finger 
and the putative E3 ubiquitin ligase activity of bICP0 because mutation of a single amino 
acid within HSV-1 ICP0 disrupts the secondary and tertiary structures of the zinc RING 
finger (Everett et al., 1995).  This conformational disruption interferes with many of the 
functions attributed to bICP0 including its ability to activate productive infection (Inman 
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et al., 2001b; Saira et al., 2008).  As we predicted, levels of ubiquitinated proteins were 
reduced in cells expressing a bICP0 zinc RING finger mutant compared to wt bICP0.  
Furthermore, during transient transfection  or productive infection (Figure 3), high levels 
of bICP0 were detected in cells expressing bICP0 proteins containing zinc RING finger 
mutants (Inman et al., 2001b; Zhang et al., 2005).  It is well established that HSV-1 ICP0 
zinc RING finger mutants have increased half-lives because they cannot induce their own 
ubiquitination (Boutell et al., 2002; Canning et al., 2004; Everett et al., 1995).  
Consequently, we suggest that in addition to other viral encoded or induced factors, 
bICP0 also regulates its own half-life by self-ubiquitination.  Additional experiments are 
required to confirm this hypothesis.  
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FIGURE 1 
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Figure 1.  Ubiquitinated proteins from cells expressing bICP0.  Neuro-2A cells were 
co-transfected with HA-tagged ubiquitin (HA-Ub) and bICP0, 13g51a, or empty 
expression vector.  The 13g51a contains single substitution mutations of two conserved 
cysteine residues within the zinc RING finger domain of bICP0.  Whole cell extracts 
were collected 48 h after transfection and subjected to western blot analysis.  Ubiquitin 
levels were monitored using an HA antibody.  
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FIGURE 2 
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Figure 2.  Ubiquitinated proteins from productively infected cells.  CRIB cells were 
mock infected, or infected with wt BHV-1 or 51g mutant at 1 MOI (A) or 5 MOI (B).  
After 1 h, media was replaced with media containing 0.015mM of the proteasome 
inhibitor lactacystin to prevent degradation of proteins.  Whole cell extracts were 
collected at 8 h post infection and analyzed by western blot.  An antibody recognizing 
full length ubiquitin was used to monitor ubiquitinated protein levels.  
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FIGURE 3 
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Figure 3.  Polyubiquitinated IRF in cells expressing bICP0.  Neuro-2A cells were co-
transfected with HA-Ub, IRF3, and bICP0 or empty expression vector.  Cells were 
treated with lactacystin prior to collection to prevent proteasome-dependent proteolysis.  
Whole cell extracts were collected at 48 h after transfection and there protein 
concentrations measured by Bradford assay.  Equal amounts of each sample were used 
for ubiquitin enrichment, a high-affinity resin system that isolates polyubiquitinated 
proteins from cell extracts (Pierce).  Ubiquitin (data no shown) and IRF3 proteins were 
detected using a ubiquitin or IRF3 antibodies, respectively.  The IRF3 protein migrates at 
approximately 50 kilo Daltons (kDa).  Ubiquitin migrates at approximately 8 kDa, and 
polyubiquitinated proteins have an added mass of at least 32 kDa. 
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FIGURE 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
Figure 4.  bICP0 protein levels during productive infection.  CRIB cells were mock 
infected, or infected with wt BHV-1, the 51g mutant, the 51g rescued virus (51gR) at an 
MOI of 1.  At 6 h after infection, some cultures were treated with 0.1 mg/ml 
cycloheximide (Sigma) (CHX; + lanes) to inhibit protein synthesis.  Two hours later (8 h 
after infection), whole cell extracts were collected and subjected to western blot analysis.  
bICP0 levels were detected using bICP0-specific polyclonal antibodies raised in rabbits.  
The bICP0 protein migrates at approximately 97 kDa, and beta actin migrates at 
approximately 42 kDa (marked at right). 
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ABSTRACT 
BHV-1 is an important pathogen of cattle.  The infected cell protein 0 (bICP0) 
encoded by BHV-1 is an important regulatory protein because it is constitutively 
expressed and can activate all viral promoters.  The mechanism by which bICP0 activates 
viral promoters is not well understood because bICP0 does not appear to be a sequence 
specific binding protein.  A C3HC4 zinc RING (really interesting novel gene) motif at the 
N-terminus of bICP0 has E3 ubiquitin ligase activity, which is important for activating 
viral gene expression and inhibiting interferon dependent transcription.  Like other 
Alphaherpesvirinae ICP0 homologues, bICP0 is associated with promyelocytic leukemia 
(PML) protein-containing nuclear domains.  During productive infection of cultured 
cells, BHV-1 induces degradation of the PML protein, which correlates with efficient 
productive infection.  In this study, we demonstrated that a plasmid expressing bICP0 
reduces steady state levels of the PML protein, and the C3HC4 zinc RING finger is 
important for PML degradation.  Surprisingly, bICP0 mutants with an intact C3HC4 zinc 
RING finger that lack a nuclear localization signal also reduces steady PML protein 
levels.  In addition, mutant bICP0 proteins that primarily localize to the cytoplasm 
induced morphological changes in transfected cells.  During productive infection, bICP0 
was detected in the cytoplasm of low-passage bovine kidney, but not established bovine 
kidney cells.  These studies demonstrated that bICP0, even when not able to efficiently 
localize to the nucleus, was able to induce degradation of the PML protein and alter the 
morphology of transfected cells.   
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INTRODUCTION 
BHV-1 infections can lead to conjunctivitis, pneumonia, genital disorders, 
abortions, and an upper respiratory infection known as bovine respiratory disease (BRD) 
or “Shipping Fever” (Saira et al., 2008; Tikoo et al., 1995).  BHV-1 can initiate BRD by 
immunosuppressing cattle (Carter et al., 1989; Griebel et al., 1987a; Griebel et al., 1990; 
Griebel et al., 1987c; Yates, 1982), which leads to secondary bacterial infections and life-
threatening pneumonia (Yates, 1982).  BRD costs the cattle industry more than $1 
billion/year in the United States ((NASS), 1996; Bowland and Shewen, 2000; Carter et 
al., 1989; Griebel et al., 1987a; Griebel et al., 1990; Griebel et al., 1987c; Ishmael, 2001; 
Kapil, 1997; Powell, 2005; Tikoo et al., 1995).  Modified live vaccines are available, and in 
general, they prevent clinical disease in adults.  However, vaccine strains are 
immunosuppressive, can cause serious disease in young calves or abortions in pregnant 
cows, and can reactivate from latency.  
Infection of permissive cells (Devireddy and Jones, 1999b) or calves (Winkler et 
al., 1999) leads to rapid cell death, in part due to apoptosis.  Viral gene expression is 
temporally regulated in 3 distinct phases: immediate early (IE), early (E), or late (L).  IE 
gene expression is stimulated by a virion component, bTIF, which interacts with a 
cellular transcription factor (Oct-1) and stimulates transcription {reviewed in (Jones, 
1998; Jones, 2003)}.  Two IE transcription units exist: IEtu1 and IEtu2.  IEtu1 encodes 
homologues of two HSV-1 proteins, ICP0 and ICP4.  IEtu2 encodes a protein similar to 
the HSV ICP22 protein.  bICP0 is crucial for productive infection because it activates all 
viral promoters (Fraefel et al., 1994; Wirth et al., 1992; Wirth et al., 1991).  The bICP0 E 
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promoter is activated by dexamethasone (Workman et al., 2009), a stimulus that induces 
reactivation from latency suggesting activation of the bICP0 E promoter is an important 
step during reactivation from latency {reviewed in (Jones, 1998; Jones, 2003)}.   
bICP0 (Inman et al., 2001b), HSV-1 encoded ICP0 (Everett et al., 1995; Everett 
and Maul, 1994; Lium and Silverstein, 1997; Parkinson and Everett, 2000), and equine 
herpesvirus 1 encoded ICP0 (Bowles et al., 1997; Bowles et al., 2000) contain a C3HC4 
zinc RING finger near their N terminus that activates productive infection.  ICP0 (Everett 
and Maul, 1994; Maul et al., 1993) and bICP0 (Inman et al., 2001b; Parkinson and 
Everett, 2000) localize with and disrupt promyelocytic leukemia (PML) protein-
containing nuclear domains.  The C3HC4 zinc RING finger domains located in bICP0 
(Diao et al., 2005) and ICP0 (Boutell and Everett, 2003; Boutell et al., 2002; Van Sant et 
al., 2001) possess intrinsic E3 ubiquitin ligase activity.  Thus, bICP0 and ICP0 can induce 
ubiquitin dependent proteolysis of specific proteins (Everett and Maul, 1994; Parkinson 
et al., 1999).  A single point mutation within the C3HC4 zinc RING finger of bICP0 
reduced the growth potential of BHV-1 in cultured cells and this recombinant virus has 
reduced virulence in cattle (Saira et al., 2008).  bICP0 also contains two transcriptional 
activation domains and a nuclear localization signal (NLS) located near its C-terminus 
(Zhang, 2005).  Deletion of sequences encompassing the NLS reduces, but does not 
eliminate, the ability of bICP0 to trans-activate a simple promoter (Saira et al., 2008; 
Saira et al., 2009; Zhang, 2005).   
In this study, we examined the association of bICP0 with PML bodies during 
productive infection, and in transfected cells.  As expected, bICP0 reduced PML levels.  
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Surprisingly, bICP0 mutant proteins that do not localize to the nucleus also reduced PML 
levels in transiently transfected cells, and had a profound effect on the morphology of 
transfected cells.  Since bICP0 was detected in the cytoplasm of infected cells during 
productive infection, we suggest that cytoplasmic localization of bICP0 is important for 
certain functions ascribed to bICP0. 
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MATERIALS AND METHODS 
 
Cells and viruses 
Rabbit skin (RS) cells, and bovine kidney (CRIB) cells were grown in monolayer 
cultures in Earle’s modified Eagle’s medium supplemented with 10% fetal bovine serum, 
penicillin (10 U/ml), and streptomycin (100 mg/ml) in a humidified 5% CO2 atmosphere 
at 37°C.  Low passage bovine kidney cells were prepared from a healthy calf that was 7 
months old.   
The BHV-1 wt Cooper strain was propagated and titrated in CRIB cells.  For 
infection studies, cells were plated onto 60 or 100 mm culture dishes 16 to 24 hours prior 
to virus infection.  Total cells per plate were counted and the multiplicity of infection 
(MOI) calculated.   
 
Expression plasmids 
The wild type and mutated bICP0 plasmids are cloned into a pCMV2C expression 
vector downstream of a Flag tag and under the control of the human cytomegalovirus 
(CMV) promoter.  The zinc RING finger mutant 13G/51A contains point mutations 
within two conserved amino acids of the C3HC4 zinc RING finger (Inman et al., 2001b).  
bICP0 C-terminus deletion mutants (∆C-terminus and ∆NcoI) were generated by deleting 
the SalI-XhoI fragment (amino acids 356 to 676) and NcoI-XhoI fragment (amino acids 
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607 to 676), respectively, from the Flag-tagged bICP0 construct (Inman et al., 2001b).  
The hemagglutinin (HA) tagged mouse PML plasmid encodes the equivalent of the 
human PML isoform I and was provided by Dr. Paul Ling (Baylor College of Medicine, 
Houston, Texas) (Plummer et al., 1969).  The HA-tag is at the C-terminus of the PML 
cDNA.  Generation of the bICP0 transposon insertion mutants were previously described 
(Zhang et al., 2005).  The transposon insertion sites were first mapped by restriction 
endonuclease digestion, and then precise insertion sites were identified by DNA 
sequencing. 
 
Western blot analysis 
CRIB or RS cells were plated in 60 mm culture dishes 16 to 24 hours prior to 
infection or transfection, respectively. Cells were infected at the specified MOI and 
transfected using TransIT-LT1 (MIR 2300, Mirus) or Lipofectamine 2000 (11668, 
Invitrogen) reagents according to the manufacturer’s protocol. At the indicated times, 
cells were washed with PBS and suspended in RIPA lysis buffer (1% NP-40, 0.1% 
sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl 
fluoride in PBS, and one tablet of complete protease inhibitor (Roche Molecular 
Biochemicals) per 10 ml). Cell lysate was incubated at 4°C with rotation for 25 minutes, 
sonicated briefly, and then clarified by centrifugation at 13,000 rpm at 4°C for 15 
minutes. Protein concentrations were quantified by the Bradford assay, and SDS 
polyacrylamide gel electrophoresis performed.  After electrophoresis, proteins were 
transferred to a polyvinylidene difluoride membrane (Immobilon-P; Millipore).  
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Membranes were blocked in Tris-buffered saline that contained 5% milk.  The following 
antibodies were purchased from Santa Cruz Biotechnology: PML (sc-5621), HA (sc-805, 
sc-7392), or -actin (sc-1616).  bICP0 was detected using a specific bICP0 polyclonal 
antibody or monoclonal anti-Flag (Sigma, F1804).  Membranes were then incubated 
overnight with the indicated primary antibody in 5% milk-containing 0.1% Tween 20–
Tris-buffered saline.  After washing with 0.1% Tween 20–Tris-buffered saline, 
membranes were incubated with donkey anti-goat (sc-2020; Santa Cruz Biotechnology), 
donkey anti-rabbit (NA934V, Amersham Biosciences), or sheep anti-mouse (NXA931, 
Amersham Biosciences) horseradish peroxidase-conjugated immunoglobulin G 
secondary antibodies diluted in blocking buffer.  Immunodetection was performed with 
enhanced chemiluminescence western blotting detection reagents (Perkin-Elmer, MA) in 
accordance with the manufacturer’s protocol.  All figures are representative of three or 
more independent experiments.  
 
Immunofluorescence    
RS cells were plated in 60 mm culture dishes containing a sterilized cover slip at 
16 hours prior to transfection. Cells were transfected as described above. For infection 
studies, RS cells were infected with BHV-1 at 1 or 5 MOI 24 hours after transfection, and 
processed for confocal microscopy at the indicated times.  Cells were washed twice with 
plain MEM and fixed with 4% para-formaldehyde for 10 minutes, followed by three 
washes with PBS. Cells were permeabilized by incubating with 100% ethanol (-20°C) for 
5 minutes. Slides were then washed three times and blocked in 3% BSA in PBS for 1 
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hour.  The designated primary antibody was incubated for 2 hours at room temperature.  
After three washes with 0.05% Tween 20 in PBS, slides were incubated with the 
secondary antibody for 1 hour in the dark. Secondary antibodies used were Alexa Fluor 
488 goat anti-rabbit (A21050), Alexa Fluor 633 goat anti-mouse (A11008), and Alexa 
Fluor 647 donkey anti-rabbit (A31573) from Invitrogen.  After slides were washed three 
times with 0.05% Tween PBS, cover slips were mounted on slides using Gel-mount 
aqueous mounting medium (G0918, Sigma).   Images were obtained with a Bio-Rad 
confocal laser-scanning microscope (MRC-1024ES) with excitation/emission at 488/520 
nm. Images are representative of three or more independent experiments.  
 
Coimmunoprecipitation 
Cell lysates were pre-cleared by incubating with rabbit serum (0.05 ml per 1 ml) 
for 1 hour on ice, followed by addition of washed protein A beads (0.05 ml slurry per 
sample) and incubated with rotation at 4°C for an additional 30 minutes.  Beads were 
pelleted and the supernatants collected for immunoprecipitation.  Samples were incubated 
with approximately 2 g bICP0 or HA polyclonal antibodies per 0.5 mg of protein 
overnight with rotation at 4°C.  PML (sc-5621) and HA (sc-805) polyclonal antibodies 
were purchased from Santa Cruz Biotechnology.  To each sample 0.1 ml of protein A 
agarose bead slurry was added and incubated at 4°C with rotation for 4 hours.  Beads 
were washed three times with lysis buffer and the protein eluted by adding 0.05 ml 2X 
loading buffer (62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate (SDS), 50 mM 
dithiothreitol, 0.1% Bromophenol Blue, 10% Glycerol) and boiling samples for 5 min.  
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Proteins were separated on an 8% SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
gel. 
 
Extraction of viral genomic DNA for b-galactosidase assay 
The BHV-1 gC blue virus has the Lac Z gene inserted downstream of the gC 
promoter, a late viral gene. CRIB cells were infected with the BHV-1 gC blue virus for 1 
h, rinsed with PBS, and replaced with fresh medium.  Cells with medium were collected 
after approximately 80% visible cytopathic effect, followed by three freeze/thaw cycles at 
-80 C.  The supernatant was clarified by centrifugation (3600 rpm 4 °C, 30 min). Virus 
was pelleted using 5ml 30% sucrose cushion to 25ml virus, by centrifugation (25000 rpm 
for 3 h in a Beckman L7-65 ultracentrifuge using an SW28 rotor at 4 °C).  The pellet was 
suspended in 900 ml of DNase I-free TE.  The virions were disrupted by adding 50ml 
20% SDS, 7.5ml of 1mg/ml RNase, and incubating the solution at 37 °C for 20 min.  
Proteinase K was added (50ml of a 10 mg/ml solution) and the solution was incubated at 
60 °C for 30 min.  Three phenol:Chloroform:isoamyl alcohol (25:24:1) extractions were 
performed, followed by two extraction with Chloroform:isoamyl alcohol (24:1).  The 
resulting aqueous layer was subjected to two extractions with ether.  DNA was 
precipitated with 2.2 volumes 100% ethanol and sodium acetate (0.3M) at -80 °C for 1 h. 
Viral DNA was pelleted by centrifuging13000 rpm for 15 min at rm temp and washed 
with 80% ethanol.  After final spin at 1300 rmp for 5 min at rm temp, pellet was 
resuspended in 100ml TE and quantified using Bio-Rad SmartSpec 3000. 
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Beta-galactosidase assay 
A similar protocol was followed as previously described.  RS cells were split to 6-
well culture plates and 16 h later transfected with a total of 2 ug DNA using 
Lipofectamine 2000 1:1 (11668, Invitrogen).  BHV-1 gC blue viral DNA (1 ug) was 
cotransfected with bICP0 at a 64:1 ratio (mg BHV-1 DNA to mg bICP0 plasmid DNA), 
and specified ratios of HA-PML plasmid. Blank expression vector was used to maintain 
equivalent amounts of DNA.  After 24 h transfection, cells were rinsed with PBS and 
fixed with 2% formaldehyde, 0.2% glutaraldehyde in PBS for 5 min.  Cells were washed 
twice with PBS and stained overnight at 4°C with 0.1% Bluo-Gal (15519-028, 
Invitrogen), 5 mM K3FE(CN)6, 5 mM K4FE(CN)6, 2 mM MgCl2 in PBS.  Cells were 
rinsed with PBS and number of blue cells counted. 
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RESULTS 
 
BHV-1 infection affects endogenous PML levels.  
BHV-1 productive infection disrupts and degrades PML nuclear body-associated 
proteins in a bICP0 dependent fashion (Inman et al., 2001b; Parkinson and Everett, 
2000).  To confirm and expand these findings, we initially examined the effect of BHV-1 
productive infection on cellular PML protein levels in bovine kidney cells (CRIB).  CRIB 
cells infected with BHV-1 at an MOI of 5 were collected at the designated times after 
infection and whole cell lysate was subjected to western blot analysis.  Several high 
molecular weight bands were recognized by the PML antiserum, which was expected 
because PML undergoes extensive post-translational modifications (Everett and Maul, 
1994).  By 8 hours after infection, endogenous PML protein levels were reduced in BHV-
1 infected cells compared to mock infected cells (Figure 1A).  Sumoylation of PML 
targets it for proteasome-dependent degradation (Lallemand-Breienbach, 2001), and ICP0 
preferentially degrades PML that is sumoylated (Boutell and Everett, 2003; Everett et al., 
1998; Parkinson et al., 1999).  Treatment of cultures with lactacystin, a proteasome 
inhibitor, partially restored PML levels in infected bovine cells (Figure 1B).  Longer 
exposure of cells to lactacystin was not possible in CRIB cells because of toxicity 
complications (data not shown).  Cellular PML protein levels were also analyzed by 
confocal microscopy at the designated times after infection.  Reduced endogenous PML 
levels were observed in rabbit skin (RS) cells productively infected with BHV-1 (Figure 
1C).  These studies confirmed that BHV-1 infection reduced PML protein levels during 
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productive infection, and demonstrated that a functional proteasome played a role in 
regulating PML protein levels.   
 
bICP0 induced proteasome-dependent degradation of PML. 
To test whether bICP0 had an effect on PML protein levels, transient transfection 
assays were performed.  RS cells were used for these studies because they are permissive 
for BHV-1 and approximately 50% of RS cells can be transfected.  Cellular PML levels 
in RS cells transiently expressing bICP0 were analyzed by western blot and confocal 
microscopy (Figure 2A, B).  Transient expression of bICP0 consistently had a modest 
effect on endogenous PML levels in rabbit skin (RS) cells (Figure 2A) or mouse 
neuroblastoma cells (data not shown).  However, the effect was not as dramatic as in 
observed in productively infected cells (Figure 1).  Consequently, we cotransfected RS 
cells with a plasmid that expresses HA-tagged PML and bICP0, and then examined PML 
levels using an anti-HA antibody.  The HA-tagged PML expression vector contains a 
mouse cDNA that encodes the equivalent of human PML isoform I (Plummer et al., 
1969).  Whole cell lysate was collected 48 hours after transfection and subjected to 
western blot analysis.  bICP0 consistently reduced HA-PML levels compared to cells 
transfected with the empty expression vector (Figure 2C).  bICP0 is an E3 ubiquitin 
ligase that targets certain proteins for proteasome-dependent degradation (Diao et al., 
2005).  To test whether the proteasome was necessary for PML degradation, RS cells co-
expressing HA-PML and bICP0 were treated with a proteasome inhibitor, lactacystin.  
Lactacystin treatment of cells transfected with the bICP0 expression plasmid has 
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consistently increased HA-PML levels (Figure 2C, lane 4).  In summary, these results 
indicated that bICP0, in the absence of other viral proteins, induced proteasome-
dependent PML degradation.  
To determine if a direct interaction could be detected between bICP0 and PML, 
coimmunoprecipitation and western blot analysis were performed.  RS cells were 
cotransfected with bICP0 or HA-PML expression plasmids.  HA-PML was detected by 
western blot with the HA antibody following immunoprecipitation with the HA antibody 
(Figure 2D, lanes 3 and 4), as expected.  However, we did not detect HA-PML from 
bICP0 immunoprecipitates of cells cotransfected with bICP0 and HA-PML (Figure 2D, 
lane 2).  Thus, we were unable to provide evidence of a direct interaction between bICP0 
and PML. 
 
Localization of bICP0 to the nucleus was not required for PML degradation.  
The effect of three bICP0 mutants on PML protein levels was analyzed by 
western blot analysis.  The 13G/51A mutant contains substitutions of two conserved 
cysteine residues within the C3HC4 zinc RING finger of bICP0 (Inman et al., 2001b) 
(Figure 3A).  The zinc RING finger is a critical functional domain of bICP0 that controls 
many of bICP0 functions (Saira et al., 2009).  The ∆C-terminus and ∆NcoI mutants do 
not contain aa sequences spanning the bICP0 NLS (Zhang, 2005). We predicted that 
disruption of the zinc RING finger domain and deletion of the NLS would interfere with 
the ability of bICP0 to reduce PML protein levels.  The 13G/51A mutant reduced HA-
PML levels less efficiently than wild type bICP0 (Figure 3B).  Other domains of bICP0 
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may also be important for inducing PML degradation because the 13G/51A mutant 
reduced HA-PML levels relative to the empty vector.  Surprisingly, the Nco1 and C 
mutants both reduced HA-PML levels at least as efficiently as wt bICP0 (Figure 3C).   
In this study (Figure 3B and 3C) and in a previous study (Inman et al., 2001b), it 
appeared steady state levels of the truncated C protein were higher than wt bICP0 or 
other mutants examined.  All of the constructs were prepared in the same expression 
vector ruling out the possibility that the vector contributed to this difference.  To estimate 
the ½ lives of the respective bICP0 protein levels, RS cells were transfected with the 
respective bICP0 expression plasmids and 24 hours later the respective cultures were 
treated with cycloheximide (CHX), an inhibitor of protein synthesis.  Whole cell extract 
was collected at 2, 4, or 8 hours after CHX treatment, and bICP0 protein levels analyzed 
by western blot analysis.  Wt bICP0 in transfected cells had a ½ life of 3-4 hours, but 
during productive infection the ½ life of bICP0 was less than 2 hours suggesting that viral 
encoded or induced factors regulated bICP0 levels during productive infection. The 
13G/51A, and Nco1 mutant had a ½ life between 4-6 hours (Figure 3A).  In contrast, 
the C mutant protein had a ½ life greater than 8 hours, which confirmed that the ∆C-
terminus protein was more stable than wt bICP0.  
 
Localization of bICP0 mutants and their effect on PML expression. 
To test whether bICP0 and the various mutant forms of bICP0 colocalized with 
PML in transfected cells, confocal microscopy was performed.  Since the ∆Nco1 mutant 
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primarily localizes to the cytoplasm and the ∆C-terminus mutant is present throughout 
cells, it was possible that PML re-localized these truncated mutants to the nucleus, and 
consequently the mutants efficiently reduced PML levels.  RS cells were cotransfected 
with HA-PML and bICP0, 13G/51A, Nco1, or C and processed for confocal 
microscopy 24 or 48 hours later.  As expected, wt bICP0 and the 13G/51A mutant co-
localized with HA-PML (Figure 4A).   Consistent to what was observed in BHV-1 
infected cells (Figure 4B), HA-PML appeared to form aggregates in cells expressing 
bICP0.  HA-PML in cells transfected with 13G/51A, Nco1, or C-terminus displayed a 
similar effect as wt bICP0.  However, we saw no evidence for PML recruiting the ∆NcoI 
and ∆C-terminus mutants to the nucleus suggesting these mutants: 1) reduced PML levels 
by an indirect mechanism, or 2) bICP0 interacted with cytoplasmic PML prior to nuclear 
translocation. 
We have consistently observed that RS cells transfected with the Nco1 or C 
mutants displayed altered morphology, multiple nuclei or loss of nuclear integrity for 
example (Figure 4C and D).  In general, the morphological effects caused by C 
expression were more severe relative to the mutant bICP0 protein encoded by the Nco1 
protein.  For example, 60% of cells transfected with the ∆C-terminus deletion mutant 
contained fragmented cells, in which a nucleus was not obvious, as judged by DAPI 
staining (Figure 4D).  More than 50% of cells transfected with the ∆NcoI mutant 
appeared to contain multi-lobed cells, and approximately 30% of the cells appeared to be 
fragmented.  In contrast, nearly 60% of cells transfected with wt bICP0 had a normal 
cellular morphology.  Cells that were not transfected contained more than 80% of the 
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cells that appeared to be normal, which was expected.  In summary, these studies 
provided evidence that non-nuclear forms of bICP0 altered the morphology of transfected 
cells, which may have led to reduced PML levels.   
 
Identification of bICP0 domains important for reducing PML protein levels.   
To test whether other bICP0 functional domains were important for reducing 
PML protein levels, several bICP0 transposon mutants (Zhang et al., 2005) were selected 
for analysis (Figure 5A).  The transposon mutants designated C, I, K, N, and O were 
selected based on their position throughout the bICP0 coding sequence, as well as their 
attenuation of certain bICP0 functions.  The C, I, K, N, and O transposon mutants were 
shown previously to attenuate the ability of bICP0 to activate a minimal HSV-1 
thymidine kinase promoter (Zhang et al., 2005).  The mutants I, N, and O lost their ability 
to inhibit IRF7 or IRF3-induced IFN- promoter activity, and the O mutant reduced IRF3 
protein levels less efficiently compared to wt bICP0 (Saira et al., 2007).   
For these studies, RS cells were cotransfected with wt bICP0 or the designated 
transposon mutants and HA-PML, followed by western blot analysis.  All of the 
transposon mutants tested reduced HA-PML levels as analyzed by western blot (Figure 
5B, top).  Although there were slight differences between the transposon mutants and 
their ability to reduce HA-PML as compared to wt bICP0, this variation was most likely 
relative to the expression level of these proteins (Figure 5B, middle).  The transposon 
mutants had previously been shown to have similar expression levels in human 293 cells 
(Zhang et al., 2005); however, differences in expression were evident throughout the 
65 
 
course of these experiments and this was most likely attributed to their ability to reduce 
PML levels.  Lower expression levels of mutants I and K were confirmed by confocal 
microscopy studies.  The mutants I, K, and O localized to the nucleus and appeared to 
have similar effects on PML organization which was consistent with what was observed 
for wt bICP0 (Figure 5C).  These studies indicate that the ability of I, K, and O to localize 
with and reduce HA-PML was not disrupted.   
 
Overexpression of PML reduced BHV-1 replication. 
Given that PML is implicated to play a role in antiviral defenses, we investigated 
whether overexpression of PML inhibited productive infection.  For this study, a BHV-1 
strain containing the Lac Z gene inserted downstream of the gC promoter was used to 
analyze expression of the BHV-1 genome.  bICP0 is a potent transcriptional activator that 
is critical for stimulating productive infection.  Therefore, we used bICP0 to induce viral 
expression.  A constant amount of viral genomic DNA was cotransfected with bICP0 and 
increasing amounts of HA-PML.  Cells were fixed and stained for beta-gal expression 24 
hours after transfection, and total positive cells were counted.  Overexpression of PML 
reduced the ability of bICP0 to stimulate BHV-1 expression (Figure 6, black bars).  The 
effect of NcoI on viral expression in cells overexpressing PML was also analyzed.  The 
NcoI mutant activated expression of the BHV-1 genome comparable to wt bICP0 as 
determined by the number of beta-gal positive cells (Figure 6, grey bars).  Similar to wt 
bICP0, overexpression of PML also appeared to have an inhibitory effect on NcoI-
induced viral genomic expression.   
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bICP0 localization during productive infection. 
A recent study demonstrated that HSV-1 ICP0 localizes to the cytoplasm during 
productive infection (Kalamvoki, 2010; Kawaguchi et al., 1997; Van Sant et al., 2001) 
suggesting bICP0 may also localize to the cytoplasm during productive infection.  To test 
this possibility, we examined the localization of bICP0 in an established bovine kidney 
cell line (CRIB) and in low passage bovine kidney cells.  In CRIB cells (Figure 7) or in 
RS cells (data not shown), at least 90% of the bICP0+ cells contained nuclear bICP0, 
even at late times after infection.  In low passage bovine kidney cells, we found that 
approximately ½ of the bICP0+ cells contained cytoplasmic bICP0 at 12 or 24 hours after 
infection (Figure 7).  At 4 hours after infection, bICP0 was detected in the nucleus of 
infected low passage bovine kidney cells.  As expected, bICP0 was not detected in 
uninfected cells.  
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DISCUSSION 
In this study, we provided evidence that bICP0, in the absence of other viral 
genes, reduced PML protein levels and a functional proteasome was important for this 
reduction (Figure 2).  When bICP0 was cotransfected with the HA-PML plasmid, 
lactacystin restored PML levels to levels comparable to cells cotransfected with the 
empty vector and HA-PML. Conversely, lactacystin treatment only partially restored 
PML protein levels during productive infection (Figure 1) suggesting additional virus-
encoded or -induced factors influence PML protein levels.  Although colocalization of wt 
bICP0 and HA-PML was observed by confocal microscopy (Figure 4A) suggesting a 
direct interaction, we did not detect a direct association between bICP0 and HA-PML by 
coimmunoprecipitation (Figure 2D).  However, this finding was not unexpected.  Since 
bICP0 is an E3 ubiquitin ligase, when bICP0 is associated with PML, PML becomes 
polyubiquitinated and is degraded.  Thus, the association between PML and bICP0 is 
transient.  Furthermore, the ability of the NcoI and C mutants that lack the nuclear 
localization signal to affect PML levels and nuclear organization similar to wt bICP0 
raises the possibility that bICP0 influences PML by an indirect mechanism.   
Although the zinc RING finger was important for PML degradation, additional 
domains of bICP0 appear to play a role because the 13G/51A mutant could still reduce 
PML protein levels when compared to the empty vector control (Figure 3B).  Thus, we 
explored other domains of bICP0 that might be important for inducing degradation of 
PML by testing several bICP0 transposon insertion mutants.  Transposon insertion near 
the N terminus downstream of the zinc RING finger domain (C and I), within the acidic 
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domain (K), or near the C-terminus (N and O) did not appear to affect the ability of 
bICP0 to localize with or reduce HA-PML levels (Figure 5).  A previous study 
demonstrated the O mutant reduced IRF3 protein levels less efficiently than wt bICP0 
(Saira et al., 2007).  However, in this study the O mutant appeared to behave similar to wt 
bICP0 with respect to its affect on PML.  Surprisingly, deletion of sequences containing 
the NLS also reduced PML protein levels in transfected cells.  Several studies have 
demonstrated that most, if not all, PML isoforms can be detected in the nucleus and 
cytoplasm (Condemine et al., 2006; Giorgi et al., 2010; Lin et al., 2004a; McNally et al., 
2008) suggesting bICP0 mutant proteins that do not localize to the nucleus (∆C-terminus 
or ∆NcoI) can interact with PML proteins in the cytoplasm and potentially induce their 
degradation.   
PML has a negative effect on HSV-1 productive infection and expression of  
ICP0 is necessary for overcoming this repression induced by PML (Everett et al., 2008; 
Everett et al., 2006).  We therefore predicted that  PML may also reduce the efficiency of 
BHV-1 productive infection.  Induced expression of bICP0 in a stably transfected cell 
line de-represses a quiescent HSV-1 genome and this ability correlates with preventing 
the recruitment of PML body associated proteins, including PML, to replication 
complexes (Everett et al., 2010).  The BHV-1 genome is not efficient at producing 
plaques when transfected into permissive cells unless bICP0 or other positive cellular 
factors are cotransfected with the genome (Geiser et al., 2002; Geiser and Jones, 2003; 
Inman et al., 2001b; Meyer, 2007).  In this assay, the ∆C-terminus mutant stimulated 
plaque forming efficiency similar to wt bICP0 (Inman et al., 2001b).  However, the ∆C-
terminus mutant does not stimulate a simple thymidine kinase promoter construct (Inman 
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et al., 2001b) suggesting that reduction of PML protein levels by the ∆C-terminus mutant 
was important for increasing the efficiency of productive infection.  The NcoI mutant 
also had reduced transcriptional activation potential relative to wt bICP0 (Zhang et al., 
2005); however, NcoI was still able to activate viral replication (Figure 6).  
Overexpression of PML appeared to have a negative effect on BHV-1 genomic 
expression in the presence of NcoI or wt bICP0 (Figure 6).  Taken together, these data 
suggest PML represses viral replication, and bICP0 subsequently relieves this repression 
by inducing PML degradation. 
The morphological changes induced by plasmids expressing the ∆C-terminus or 
∆NcoI deletion mutants suggested these cells would not be viable for long periods of 
time.  A previous study demonstrated that bICP0 and the ∆C-terminus mutant indirectly 
induced apoptosis, as judged by casapse 3 activation, in mouse neuroblasoma cells 
(neuro-2A) (Henderson, 2004) and (data not shown).  In contrast, we were unable to 
detect activated caspase 3 in RS cells expressing either the Nco1 or C-terminus 
mutants (data not shown) indicating bICP0-induced apoptosis in neuro-2A cells, but not 
RS cells.  We further suggest that degradation of non-nuclear PML by the Nco1 or C-
terminus mutants in RS cells may affect apoptosis because non-nuclear PML promotes 
apoptosis at the endoplasmic reticulum by modulating calcium release (Giorgi et al., 
2010).  In addition to non-nuclear PML being enriched at the endoplasmic reticulum, 
PML is also enriched at mitochondria-associated membranes, and non-nuclear PML is 
associated with a protein kinase (AKT) that inhibits apoptosis (Giorgi et al., 2010).  
These observations suggested that bICP0 expression has different effects on cell survival.  
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For example, bICP0 can have a toxic effect on cells, but by reducing PML bICP0 may 
also interfere with specific apoptotic stimuli.  There is precedence for bICP0 regulating 
cell type dependent cell death because BHV-1 induces cell type dependent cell death and 
deletion of bICP0 influences the outcome (Geiser, 2008).  Clearly, additional studies are 
needed to understand how bICP0 regulates cell survival.   
HSV-1 ICP0 is consistently detected in the cytoplasm of infected cells, regardless 
of whether the cells are low-passage or established (Kalamvoki, 2010; Kawaguchi et al., 
1997; Van Sant et al., 2001).  Although bICP0 was localized to the cytoplasm during late 
stages of infection in low-passage bovine kidney cells, this was not the case in 
established bovine kidney cells (CRIB) or RS cells (data not shown).  Whether all low 
passage bovine cells contain bICP0 in the cytoplasm is unknown.  Regardless of whether 
bICP0 is localized in the cytoplasm during productive infection, we predict cytoplasmic 
localized bICP0 plays a role during productive infection.  For example, it is known that 
HSV-1 ICP0 blocks activation of the interferon response factor 3 only when it is in the 
cytoplasm (Paladino, 2010), and cytoplasmic ICP0 reorganizes microtubules (Liu, 2010).   
Recent work from our lab has shown cytoplasmic bICP0 is able to inhibit IFN- 
promoter activity and induce degradation of IRF3 as efficiently as wt bICP0 (Da Silva 
and Gaudreault, unpublished).  These data suggest a role for cytoplasmic bICP0 in 
repressing the innate immune response and altering cell fate after infection.  Studies to 
address how bICP0 is moved to the cytoplasm in low-passage cells and what role 
cytoplasmic bICP0 plays during productive infection are in progress. 
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FIGURE 1 
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Figure 1.  BHV-1 productive infection reduces PML protein levels. 
Panel A: CRIB cells were mock infected or infected with BHV-1 (MOI=5) and whole 
cell lysate collected at the indicated time points after infection (hours) as described in the 
materials and methods. Anti-PML or anti--actin antibodies were used for western blot 
analysis of endogenous protein levels.   
Panel B: CRIB cells were infected (MOI=5) for 8 hours followed by treatment with 15 
uM lactacystin (70980, Cayman Chemical) for 4 h.  Whole cell lysate was collected for 
western blot analysis at 12 hours after infection as described in the materials and 
methods. Anti-PML or anti--actin antibodies were used for western blot analysis of 
endogenous protein levels.   
Panel C:  RS cells were infected (MOI=5) and processed for confocal microscopy at the 
indicated times after infection.  Primary anti-PML and secondary Alexafluor-488 (green) 
antibodies were used to visualize endogenous protein expression.  DAPI (blue) was used 
to stain nuclear DNA. 
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FIGURE 2 
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Figure 2.  bICP0 induces proteasome-dependent degradation of PML. 
Panel A:  RS cells were transfected with the plasmid expressing wt bICP0 or the empty 
vector (pcDNA3.1).  At 40 hours after transfection, PML, bICP0, or -actin levels were 
examined by Western Blot analysis.   
Panel B:  RS cells were transfected with bICP0 and processed for confocal microscopy 
24 h later.  Cells were stained with anti-PML and anti-bICP0 antibodies, followed by 
secondary labeling with Alexafluor-633 and -488 for visualization of PML and bICP0 
expression, respectively. 
Panel C:  RS cells were transfected with the HA-PML expression plasmid and the wt 
bICP0 plasmid or blank expression vector.  Where indicated, cells were treated with 15 
uM lactacystin (70980, Cayman Chemical) for 8 hours before preparation of whole cell 
lysate.  Whole cell lysate was prepared at 48 hours after transfection and western blot 
analysis performed.  Anti-PML anti--actin antibodies were used to detect endogenous 
protein levels.  Transiently expressed HA-PML and bICP0 were detected using anti-HA 
and anti-bICP0 antibodies. 
Panel D:  RS cells were cotransfected with HA-PML, and bICP0 or empty vector.  
Whole cell lysates were collected 40 hours after transfection and subjected to 
immunoprecipitation (IP) with HA or peptide specific bICP0 polyclonal antibodies.  
Immunoprecipitated proteins were analyzed by western blot (WB) with the HA antibody.  
The HA-PML protein migrates between 95 and 100 kilo Daltons (kDa). 
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FIGURE 3 
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Figure 3.  Effect of bICP0 mutants on PML levels. 
Panel A: Schematic of wt bICP0 and C-terminal deletion mutants.  Positions of the zinc 
RING finger and acidic domain are indicated.  The NLS core sequence is from amino 
acid 622-625.  The zinc RING finger mutant (13G/51A) has two well-conserved C’s that 
were mutagenized to G and A respectively (Inman et al., 2001b).  The ∆NcoI mutant has 
aa sequences from 607-676 deleted (Zhang, 2005).  The ∆C-terminus construct contains a 
large deletion after amino acid 356 (Inman et al., 2001b).  To estimate the ½ life of the 
various bICP0 mutants, RS cells were transfected with the indicated bICP0 plasmids and 
24 hours later cultures were treated with cycloheximide (100 ug/ml) for 2, 4, 6, or 8 
hours.  Cells were then collected, whole cell lysate was prepared, and bICP0 protein 
levels determined by western blot analysis.  bICP0 protein levels were estimated using 
the Quantity One volume analysis program after obtaining images of the gels using a 
BioRad Molecular Imager FX.  The results from 3 independent experiments were 
averaged. 
Panels B and C:  RS cells were cotransfected with the indicated bICP0 expression 
plasmid or blank expression vector and the HA-PML expression vector, and processed 
for Western Blot analysis at 48 hours after transfection.  Transiently expressed HA-PML 
and bICP0 were detected using anti-HA and anti-bICP0 antibodies.  These studies are 
representative of three or more independent experiments. 
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FIGURE 4 
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Figure 4.  ∆NcoI and ∆C-terminus mutants do not co-localize with PML in the 
nucleus of transfected cells. 
Panel A:  RS cells were cotransfected with the designated bICP0 plasmids and the HA-
PML expression vector.  Cells were stained with anti-HA and anti-bICP0 antibodies, 
followed by secondary labeling with Alexafluor-633 and -488 for visualization of PML 
and bICP0 expression, respectively.  The studies were repeated at least 4 times and the 
results were consistent. 
Panel B:  RS cells were transfected with HA-PML.  After 24 h cells were infected with 
BHV-1 (MOI=5) and processed for confocal microscopy 8 h later.  Cells were stained 
with anti-HA and anti-bICP0 antibodies, followed by secondary labeling with 
Alexafluor-633 and -488. 
Panel C and D:  RS cells were transfected with the Nco1 or C-terminus plasmids and 
processed for confocal microscopy 24 hours later.  RS cells were stained with propidium 
iodide (PI) for 15 minutes at room temperature prior to fixation.  An anti-flag antibody 
was used to detect bICP0 expression.  DAPI was used to stain nuclear DNA.    
Panel E:  From transfection studies described in panels A and B, the % of bICP0+ cells 
that appeared normal, contained multi-lobed cells, and those that contained a fragmented 
cell were estimated.  As a control, untransfected cells in the same dish were also counted.  
For each sample, at least 300-400 cells were counted from 4 different transfections. 
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FIGURE 5 
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Figure 5.  Identification of bICP0 domains important for inducing PML 
degradation.  
Panel A:  Schematic of bICP0 transposon insertion mutants.  Construction and 
identification of the transposon insertion mutants were previously described (Zhang et al., 
2005).  The mutants were designated A to O, and the numbers in parentheses denote the 
amino acid number that was disrupted by transposon insertion.  The positions of the zinc 
RING finger, acidic domain, consensus NLS (KRRR), ATG, and bICP0 stop codon are 
shown.  The transposon mutants that had a dramatic effect on activating the thymidine 
kinase promoter are underlined.  The mutants selected for analysis in this study are 
circled in red.  RS cells were cotransfected with the designated bICP0 plasmids and the 
HA-PML expression vector.   
Panel B:  RS cells were processed for western blot analysis 40 h after transfection.  
Transiently expressed HA-PML and bICP0 were detected using anti-HA and anti-bICP0 
antibodies.   
Panel C:  RS cells were processed for confocal microscopy 40 h after transfection.  Cells 
were stained with anti-HA and anti-bICP0 antibodies, followed by secondary labeling 
with Alexafluor-633 and -488 for visualization of PML and bICP0 expression, 
respectively. 
 
 
 
82 
 
FIGURE 6 
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Figure 6.  Overexpression of PML reduced BHV-1 replication. 
RS cells were transfected with a constant amount of viral genomic DNA isolated from gC 
blue BHV-1 infected cells, a constant amount of bICP0 (black bars) or NcoI (grey bars), 
and increasing amounts of HA-PML.  Blank expression vector was used to ensure each 
reaction contained equal amounts of DNA.  Cells were fixed 24 hours after transfection 
and beta-galactosidase assay performed.  Total beta-gal positive cells were counted for 
each sample and values of 3 independent experiments were averaged. 
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FIGURE 7 
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Figure 7.  Localization of bICP0 during productive infection. 
Established bovine kidney cells (CRIB) or low passage bovine kidney cells (BK) were 
infected with BHV-1 (MOI=5).  At the designated times after infection (hours), confocal 
microscopy was performed using the bICP0 antibody.  To visualize nuclei, DAPI staining 
was performed. 
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CHAPTER 4 
 
Studies designed to identify novel bICP0 interacting proteins. 
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ABSTRACT 
 Bovine herpes virus type 1 (BHV-1) encoded infected cell protein 0 (bICP0) plays 
a critical role during the BHV-1 infectious cycle.  bICP0 is a promiscuous transcriptional 
activator and inhibitor of the host interferon response.  The bICP0 protein has been 
shown to directly associate with the chromatin remodeling enzyme histone deacetylase 1 
(HDAC1) to promote expression of viral genes, and interferon regulatory factor 7 (IRF7) 
and histone acetyltransferase p300 to inhibit interferon beta (IFN-) transcription.  In this 
study, we attempted to identify other proteins that are associated with bICP0 by coaffinity 
purification and mass spectrometry analysis.  Identification of bICP0 interacting proteins 
would aid in the elucidation of the underlying mechanisms of this important viral protein.  
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INTRODUCTION 
BHV-1 encoded bICP0 is a multifunctional protein that is critical for viral 
replication and virulence (Jones, 2009).  During productive infection, viral genes are 
temporally expressed in three distinct phases: immediate early, early, and late (Jones, 
1998; Jones, 2003; Wirth et al., 1989).  Expression of bICP0 is activated by an immediate 
early as well as an early promoter, and constitutive levels are expressed throughout 
productive infection (Wirth et al., 1992; Wirth et al., 1989; Wirth et al., 1991).  bICP0 is 
a known promiscuous activator of viral gene expression and is required for efficient viral 
replication (Fraefel et al., 1994; Wirth et al., 1992; Wirth et al., 1991).  Not only is bICP0 
a potent activator of all three classes of viral genes, it also represses interferon dependent 
transcription (Henderson et al., 2005; Saira et al., 2007; Saira et al., 2009).  Its ability to 
stimulate productive infection and regulate innate immune responses makes bICP0 a 
critical component of the BHV-1 infectious cycle. 
During productive infection bICP0 localizes to and disrupts promyelocytic 
leukemia (PML) protein containing domains (Gaudreault and Jones, 2011; Inman et al., 
2001b).  bICP0 contains a C3HC4 zinc RING finger motif which possesses intrinsic E3 
ubiquitin ligase activity  and has been shown to induce the proteasome dependent 
degradation of specific cellular proteins, including PML and interferon regulatory factor 
3 (IRF3) (Diao et al., 2005; Gaudreault and Jones, 2011; Saira et al., 2007).  The bICP0 
protein directly associates with histone deacetylase 1 (HDAC1) to promote viral gene 
expression (Zhang and Jones, 2001).  It has also been shown to have a direct interaction 
with the histone acetyltransferase p300 and IRF7 to inhibit IFN- activation (Saira et al., 
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2009; Zhang et al., 2006).  It is clear bICP0 plays multiple roles during productive 
infection; however, the specific mechanisms underlying bICP0 functions are not well 
understood.  Due to its multiple roles and influence on host responses during infection, it 
is likely that bICP0 interacts with a number of cellular as well as BHV-1 encoded 
proteins.     
The bICP0 protein is known to be a nuclear localizing protein, yet during the 
course of infection bICP0 can shuttle between the nucleus and cytoplasm.  We recently 
demonstrated that bICP0 localizes to the cytoplasm of low passage bovine cells at later 
times of infection (Gaudreault and Jones, 2011).  These findings suggest a role for 
cytoplasmic bICP0 during productive infection.  Therefore, it is probable that bICP0 
associates with proteins in the cytoplasm in addition to nuclear proteins.  Identifying 
proteins that interact with bICP0 would provide insight into the molecular mechanisms, 
as well as, additional functions of bICP0 during productive infection.  We therefore set 
forth to identify bICP0 binding partners by coaffinity purification and mass spectrometric 
analysis. 
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MATERIALS AND METHODS 
 
Cells and virus 
Bovine kidney (CRIB) cells and rabbit skin cells (RS) were grown in monolayer 
cultures in Earle’s modified Eagle’s medium supplemented with 10% fetal bovine serum 
(FBS), penicillin (10 U/ml), and streptomycin (100 mg/ml) in a humidified 5% CO2 
atmosphere at 37°C.  The BHV-1 Cooper strain was propagated and titrated in CRIB 
cells.  For infection studies, cells were plated onto 60 or 100 mm culture dishes 16 to 24 
hours prior to virus infection.  Total cells per plate were counted and the specified 
multiplicity of infection (MOI) calculated.   
 
Expression plasmid and transfection 
The wild type bICP0 plasmid is cloned into a pCMV2 expression vector 
downstream of a Flag tag and under the control of the human cytomegalovirus (CMV) 
promoter.  Empty vector was included as a negative control.  RS cells were plated onto 
60 mm culture dishes 16 to 24 hours prior to transfection.  RS cells were transfected 
using the TransitIT-LT1 reagent (MIR 2300, Mirus) according to the manufacturer’s 
protocol.   
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Metabolic labeling of cells with [35]S-methionine  
CRIB cells were infected with BHV-1 at an MOI of 5 for 3 hours.  Cells were 
then washed with PBS and incubated with 2% dialyzed FBS methionine-cysteine free 
EMEM starvation media for 1 hour (Sigma).  For radiolabeling of proteins 0.1 mCi 
[35]S-methionine was added to cultures and incubated for an additional 2 hours.  Cells 
were collected for lysis with RIPA buffer (1% Nonidet P-40, 0.1% sodium dodecyl 
sulfate (SDS), 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride in PBS, 
and one tablet of complete protease inhibitor [Roche] per 10 ml).  Cell lysate was 
incubated at 4°C with rotation for 25 min, sonicated briefly, and then clarified by 
centrifugation at 13,000 rpm at 4°C for 15 min.  
 
Coimmunoprecipitation 
Cell lysates were pre-cleared by incubating with rabbit serum (0.05 ml per 1 ml) 
for 1 hour on ice, followed by addition of washed protein A agarose beads (0.05 ml slurry 
per sample) and incubated with rotation at 4°C for an additional 30 minutes.  Beads were 
pelleted and the supernatants collected for immunoprecipitation.  Samples were incubated 
with approximately 2 g bICP0 polyclonal antibody per 0.5 mg of protein overnight with 
rotation at 4°C.  To each sample, 0.1 ml of protein A agarose bead slurry was added and 
incubated at 4°C with rotation for 4 hours.  Beads were washed three times with lysis 
buffer and the protein eluted by adding 0.05 ml 2X loading buffer (62.5 mM Tris-HCl pH 
6.8, 2% SDS, 50 mM dithiothreitol, 0.1% Bromophenol Blue, 10% Glycerol) and boiling 
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the samples for 5 min.  Proteins were separated on an 8 or 10% SDS poly acrylamide gel 
electrophoresis (SDS-PAGE). 
 
Western blot analysis 
Protein concentrations were quantified by the Bradford assay, and SDS-PAGE.  
After electrophoresis, proteins were transferred to a polyvinylidene difluoride membrane 
(Immobilon-P; Millipore).  Membranes were blocked in Tris-buffered saline that 
contained 5% milk.  The beta-actin antibody (sc-1616) was purchased from Santa Cruz 
Biotechnology.  bICP0 was detected using a bICP0 peptide specific rabbit polyclonal 
antibody.  Membranes were then incubated overnight with the indicated primary antibody 
in 5% milk-containing 0.1% Tween 20–Tris-buffered saline.  After washing with 0.1% 
Tween 20–Tris-buffered saline, membranes were incubated with donkey anti-goat (sc-
2020; Santa Cruz Biotechnology), donkey anti-rabbit (NA934V, Amersham 
Biosciences), or sheep anti-mouse (NXA931, Amersham Biosciences) horseradish 
peroxidase-conjugated immunoglobulin G secondary antibodies diluted in blocking 
buffer.  Immunodetection was performed with enhanced chemiluminescence western 
blotting detection reagents (Perkin-Elmer, MA) in accordance with the manufacturer’s 
protocol.  Experiments were repeated three or more times. 
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Mass spectrometric analysis 
The protein gel was stained with coomassie blue and bands of interest were 
excised for mass spectrometric analysis at the Nebraska Center for Mass Spectrometry 
facility located at the University of Nebraska-Lincoln (UNL).  Further processing of the 
samples to be analyzed was performed by the sequencing facility. 
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RESULTS 
 
Identification of bICP0 binding proteins. 
In an effort to identify novel bICP0 interacting proteins in BHV-1 infected cells, 
we performed affinity purification of bICP0 with its putative binding partners which we 
sent for mass spectrometric analysis.  Initially, to determine if we could detect unique 
bands that could be excised and submitted for sequencing, we metabolically labeled 
proteins of BHV-1 infected cells with radioactive [35]S-methionine.  To maximize bICP0 
protein levels, cells were infected at 5 MOI and whole cell extracts collected 5 hours post 
infection to avoid cytopathic effect of the virus on the cells.  Protein extracts were 
immunoprecipitated with a peptide-specific bICP0 polyclonal antibody, the proteins 
separated by SDS-PAGE, and then visualized by autoradiography.  We reproducibly 
detected multiple distinguishable bands from bICP0 immunoprecipitates of BHV-1 
infected cell extracts that were not evident in mock samples that are denoted by the 
asterisks (Figure 1A).  A tenth of the protein extracts used for immunoprecipitation were 
loaded as input (Figure 1B).   
With regards to sample submission guidelines of the Nebraska Center for Mass 
Spectrometry at UNL, we prepared non-radiolabeled proteins from BHV-1 infected or 
mock infected cells to send for mass spectrometry.  Previous experimental conditions 
were scaled up in order to achieve visualization of unique protein bands by coomassie 
blue staining of the protein gel.  In addition, a set of bICP0 immunoprecipitates from 
extracts of RS cells transfected with bICP0 or empty expression vector were also 
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analyzed (Figure 2).  RS cells were chosen for bICP0 overexpression because higher 
transfection efficiency can be achieved in these cells compared to CRIB cells.  Distinct 
bands in bICP0 immunoprecipitates from BHV-1 infected or bICP0 transfected cell 
extracts were consistently observed by coomassie blue gel staining (Figure 2).  When RS 
cells were transfected with a bICP0 expression construct, novel coomassie stained bands 
were also detected (Figure 3). 
Bands of interest were excised and sent for further processing and mass 
spectrometric analysis at the UNL mass spectrometry facility.  The same regions from the 
mock or empty vector samples were also analyzed as a negative control to rule out non-
specific binding to the resin during the purification process.  Four independent sets of 
samples were submitted for sequencing.  A fraction of the bICP0 immunoprecipitated 
sample was analyzed by western blot with bICP0 antiserum to confirm the efficiency of 
the immunoprecipitation.  bICP0 was easily detected by western blot in bICP0 
immunoprecipitates of BHV-1 infected cell extracts and absent in mock samples, as 
expected (Figure 4, top).   Equal amounts of mock infected and BHV-1 infected protein 
samples were subjected to immuno-purification as demonstrated by input levels of beta 
actin (Figure 4, bottom).  Although differences between mock and infected samples were 
visibly observed, sequencing results did not clearly distinguish between proteins of mock 
and infected samples.  Furthermore, proteins unique to BHV-1 infected or bICP0 
transfected samples were not consistently observed.   
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DISCUSSION 
Because of its multiple roles during productive infection, we predicted that bICP0 
interacts with a variety of cellular proteins.  Thus far, bICP0 has been shown to directly 
associate with HDAC, p300, and IRF7 (Saira et al., 2009; Zhang et al., 2006; Zhang and 
Jones, 2001).  Although bICP0 has been shown to affect other cellular proteins such as 
PML and IRF3, a direct interaction was not evident (Gaudreault and Jones, 2011; Saira et 
al., 2007).  Furthermore, bICP0 is able to activate viral transcription (Inman et al., 2001b; 
Zhang et al., 2006; Zhang and Jones, 2001; Zhang et al., 2005), yet there is no evidence 
to indicate that bICP0 binds directly to DNA .  This implies bICP0 interacts with other 
regulatory factors to induce these effects and to stimulate viral gene expression.   
Co-affinity purification and mass spectrometry analysis of proteins has been a 
successful system for identifying novel protein-protein interactions.  At the present, no 
bICP0-protein interactions have been confirmed from the sequencing results obtained 
from these experiments.  The mass spectrometry data revealed virtually identical results 
from extracts of cells infected with BHV-1 or transiently expressing bICP0, and the mock 
controls.  Furthermore, proteins that were unique from infected or bICP0 expressing 
extracts were not consistently observed.  It is possible that similar proteins were present 
in both mock and infected samples, but at different concentrations which was not evident 
from the mass spectrometry results.  Therefore it is difficult to discern what is purely 
non-specific background and what protein interactions are specific.  The bICP0 protein 
was easily detected by western blot from bICP0 immunoprecipitates of BHV-1 infected 
cell extracts, but not from mock infected samples (Figure 4) suggesting sufficient 
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isolation of bICP0 was achieved.  It is possible that the isolation and purification 
conditions were not optimal for retaining weak interacting proteins, or that putative 
binding proteins were unstable and degraded by proteases.  However, this is unlikely 
since a cocktail of protease inhibitors was used throughout the affinity purification 
process.  Furthermore, unique bands were detected in bICP0 immunoprecipitates 
prepared from BHV-1 infected or bICP0 transfected cells compared to mock or empty 
vector expressing samples (Figures 1, 2 and 3).  This suggests complications may have 
occurred during processing of the samples for analysis by mass spectrometry, or perhaps 
due to the search parameters used for generating the protein analysis data.   
Other affinity-purification systems, such as biotin-streptavidin tagging of proteins 
could enhance binding and purification of bICP0 interacting proteins.  Separation of 
bICP0 immunoprecipitated proteins on a two-dimensional gel would allow better 
isolation of proteins and perhaps easier identification.  Alternative approaches such as 
yeast two-hybrid screening or protein microarrays have also been successful approaches 
to identify viral interacting proteins in other infectious virus systems.  Although we have 
not confirmed any novel bICP0 binding proteins from these mass spectrometry results, 
our initial results clearly showed visibly unique proteins.  Identification of interacting 
factors is a worthwhile endeavor and potential results could provide insight to the 
underlying mechanisms of bICP0 functions and enhance our understanding of bICP0’s 
role during the BHV-1 infectious cycle. 
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FIGURE 1 
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Figure 1.  Metabolically labeled proteins of bICP0 immunoprecipitates from BHV-1 
infected cells.  CRIB cells were infected at an MOI of 5.  After 3 hours of infection, cells 
were washed and incubated with 2% dialyzed FBS methionine-cysteine free EMEM 
starvation media for 1 hour.  Proteins were radiolabeled with 0.1 mCi [35]S-methionine 
for an additional 2 hours.  Whole cell protein extracts were collected and 
immunoprecipitated with a bICP0 peptide specific polyclonal antibody.  Following 
separation by SDS-PAGE, the gel was dried and exposed to a phosphorimaging screen 
and analyzed using a Bio-Rad Molecular Imager FX.  
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FIGURE 2 
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Figure 2.  bICP0 immunoprecipitated proteins from BHV-1 infected cells.  CRIB 
cells were infected at an MOI 5 and whole cell extracts collected 5 hours post infection.  
Extracts from infected or mock infected cells were used for immunoprecipitation with a 
bICP0 specific antibody.  Proteins were separated by SDS-PAGE and visualized by 
coomassie blue stain.  Sections from the gel outlined in red were excised from the gel and 
sent to the UNL sequencing facility for further processing and analysis by mass 
spectrometry.  The asterisk (*) denotes regions where unique bands were consistently 
observed.  Panels A, B and C are coomassie blue stained gels from independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
102 
 
FIGURE 3 
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Figure 3.  bICP0 immunoprecipitated proteins from bICP0 transfected cells.  RS 
cells were transfected with bICP0 or empty vector and whole cell lysates were collected 
40 hours after transfection.  Protein extracts from transfected cells were used for 
immunoprecipitation with a bICP0 specific antibody.  Proteins were separated by SDS-
PAGE and visualized by coomassie blue stain.  The panels to the right are magnified to 
exhibit more clearly the unique banding patterns in this region.  Sections from the gel 
outlined in red were excised from the gel and sent to the UNL sequencing facility for 
further processing and analysis by mass spectrometry. 
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FIGURE 4 
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Figure 4.  Isolation of bICP0 proteins from BHV-1 infected cells.  A portion of the 
protein extracts recovered from immunoprecipitation and beta actin levels from the input 
prior to immunoprecipitation were analyzed by western blot using a bICP0 specific 
antibody or antibodies recognizing beta actin, respectively.  The bICP0 protein migrates 
at approximately 97 kilo Daltons (kDa) and beta actin at approximately 42 kDa. 
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CHAPTER 5 
 
Evaluation of the infectivity of wt BHV-1 and a bICP0 zinc RING finger mutant 
virus in cancer cells. 
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ABSTRACT 
Type 1 interferons (IFN), IFN- and IFN-, play a major role in the recognition 
and response against viral infections.  In many types of cancers, the IFN pathway has 
been disrupted, allowing certain viruses that are inhibited by IFN to grow in these types 
of transformed cells.  BHV-1 encoded bICP0 plays a key role in controlling the IFN 
response by inhibiting the induction of IFN-expression.  Previous work demonstrating 
restriction of BHV-1 by the IFN signaling pathway and a recent study which investigated 
the oncolytic properties of BHV-1, prompted us to examine BHV-1 expression in cancer 
cells which possess potential defects in their IFN pathway.  To learn more about how 
BHV-1 infection may be regulated by IFN, and furthermore, the importance of bICP0 in 
the context of control of IFN, we tested the growth of wt BHV-1 and a bICP0 zinc RING 
finger mutant virus (51g) in cancer cells.  We hypothesized that potential defects in the 
IFN pathway of these transformed cell lines could relieve repression of BHV-1 
replication and the restricted growth properties of the 51g virus.  Due to the instability of 
the 51g virus, reversion of the mutation to wt was a complication during the course of 
these experiments.   
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INTRODUCTION 
The type 1 IFN response plays a major role in the recognition and defense against 
viral infections (Katze et al., 2002; Kawai and Akira, 2006; Samuel, 2001; Uematsu and 
Akira, 2006).  Type 1 interferons (IFN-, IFN-) secreted by activated cells bind to 
specific receptors on the surface of nearby cells to induce expression of interferon 
stimulated genes (ISGs), which subsequently stimulate a cascade of innate immune 
signaling pathways.  BHV-1 and human herpes simplex virus type 1 (HSV-1) share 
similar life cycle and biological properties, and replication of both viruses appears to be 
inhibited by IFN.  As a countermeasure, these viruses encode analogous ICP0 proteins 
which have important biological functions that act against the IFN antiviral defense 
(Eidson et al., 2002; Lin et al., 2004b; Mossman and Smiley, 2002) Jones, 2009).  HSV-1 
infection is regulated by IFN pathways in mice (Halford et al., 2006; Leib et al., 1999), 
and HSV-1 genomes that do not express ICP0 are more sensitive to IFN treatment in 
cultured cells (Harle et al., 2002; Mossman et al., 2000).  Expression of the HSV-1 
encoded ICP0 protein can inhibit the repressive effects of ISGs on HSV-1 and improve 
replication efficiency (Everett and Orr, 2009).  
BHV-1 encoded bICP0 plays a key role in controlling the IFN response by 
inhibiting the induction of IFN-.  bICP0 inhibits IFN- transcriptional activation by 
affecting at least three major regulators of IFN- expression:  Interferon Regulatory 
Factor 3 (IRF3), IRF7, and p300 (Saira et al., 2007; Saira et al., 2009; Zhang et al., 2006).  
IFN- is a branch of the type I IFN response pathway that plays a pivotal role in 
amplification of innate immunity and antiviral defense (Katze et al., 2002; Randall and 
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Goodbourn, 2008).  IRF3 and IRF7 are key components of the IFN response pathway, 
because they act as co-activators of the IFN- promoter (Hiscott, 2007).  p300 is a co-
activator of IRF3-dependent IFN signaling and other antiviral signaling cascades 
(Hiscott, 2007; Vo and Goodman, 2001; Weaver et al., 1998; Yoneyama et al., 1998).  
bICP0 is able to inhibit IFN- promoter activity by inducing proteasome-dependent 
degradation of IRF3 (Saira et al., 2007).  In addition, bICP0 associates with IRF7 and this 
interaction also inhibits activation of the IFN- promoter (Saira et al., 2009).  The 
interaction between bICP0 and p300 may also interfere with p300-stimulated antiviral 
signaling (Zhang et al., 2006).  Furthermore, mice infected with BHV-1 do not display 
clinical symptoms; however, mice lacking type I and type II IFN receptors in the context 
of a RAG-2 gene deletion do not survive BHV-1 infection (Abril et al., 2004).   
In many types of cancers, the IFN signaling pathway does not function properly 
(Hanahan and Weinberg, 2000).  This allows certain viruses that are inhibited by IFN to 
grow in certain tumor cell lines.  This observation has given rise to the development of 
oncolytic viruses as viral vaccines that can be used for the treatment of cancers (Bourke 
et al., 2011; Vaha-Koskela et al., 2007).  Oncolytic virotherapy is a promising means to 
treat certain non-operable tumors.  Consequently, a number of viruses are being 
specifically engineered for this purpose (Cervantes-Garcia et al., 2008; Kelly and Russell, 
2007).  HSV-1 ICP0-null oncolytic vectors are being generated for the use of cancer 
therapy (Hummel et al., 2005), and more recently BHV-1 has been implicated as a novel 
oncolytic virus with promising application for cancer virotherapy (Rodrigues et al., 
2010).  Compared to HSV-1, BHV-1 has a very strict host range (Murata et al., 1999).  
BHV-1 does not grow in normal rodent or human cells, but can replicate in certain 
110 
 
immortalized and transformed human cell types (Hammon et al., 1963; Murata et al., 
1999; Rodrigues et al., 2010).  This property has made BHV-1 a promising candidate for 
use as an oncolytic viral vector which was recently proposed (Rodrigues et al., 2010).  
The ability of BHV-1 to propagate in a number of normal, immortalized, and transformed 
human cell lines was investigated, and BHV-1 was shown to preferentially replicate in 
cells that were either immortalized or transformed (Rodrigues et al., 2010).   
In this study, we examined the replication of BHV-1 in a cancer cell line (U2OS) 
that have putative defects in its IFN pathway.  We wanted to compare the growth 
potential of a bICP0 zinc RING finger mutant virus (51g) that has restricted growth 
properties in calves and cultured cells (Saira et al., 2008), with wt BHV-1 in atypical cells 
in which the IFN system was defective.  We hypothesized that the restricted growth 
properties of the 51g mutant may, in part, be due to the inability of the virus to inhibit the 
repressive effects of the IFN pathway.  We investigated whether the potential defects in 
the IFN pathway of these transformed cell lines could relieve inhibition of the 51g virus 
to replicate efficiently.  Therefore, we set forth to examine the viral growth kinetics and 
gene expression profiles of wt BHV-1 and the 51g mutant virus in normal and cancer 
derived cells.   
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MATERIALS AND METHODS 
 
Cells and virus 
P19 murine embryonic teratocarcinoma cells, U2OS human osteocarcinoma cells, 
bovine kidney (CRIB) cells, and low passage bovine turbinate (BT) cells were grown in 
monolayer cultures in Earle’s modified Eagle’s medium supplemented with 10% fetal 
bovine serum (FBS), penicillin (10 U/ml), and streptomycin (100 mg/ml) in a humidified 
5% CO2 atmosphere at 37°C.  The wt BHV-1 Cooper strain was obtained from the 
National Veterinary Services Laboratory, Animal and Plant Health Inspection Services 
(Ames, IA).  Construction of the BHV-1 bICP0 zinc RING finger domain mutant (51g) 
was described previously (Saira et al., 2008).  BHV-1 Strains were propagated and 
titrated in CRIB cells.  For infection studies, cells were plated onto 60 or 100 mm culture 
dishes 16 to 24 hours prior to virus infection.  Total cells per plate were counted and the 
specified multiplicity of infection (MOI) calculated.  Cells were infected with the wt 
BHV-1 or 51g at an MOI of 1.0, and were harvested at the indicated times after infection. 
 
RNA extraction and reverse transcription (RT) PCR  
 Total RNA was extracted from cells using Trizol reagent (Invitrogen, Cat# 15596-
018) as described by the manufacturer.  RNA was treated with DNase I (Invitrogen) and 
subjected to reverse transcription using SuperScript III reverse transcriptase (Invitrogen) 
according to manufacture protocol.  RNA was reverse transcribed using oligo(dT) 
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primers (Invitorogen).  Ten percent of the generated cDNA was used as template for PCR 
using GoTaq DNA polymerase (Promega).  The following primer sequences were used to 
amplify viral transcripts:  bICP0 forward primer 5’-TGC AGT CTC TCA TCC ACA GC-
3’ and reverse primer 5’-GCG ACC CGG TCA ATA AAC T-3’; bICP4 forward primer 
5’-CTG CAG GAG GAA CAG CTT CT-3’ and reverse primer 5’-GTG TTC GTG CCG 
GAG ATG-3’; bICP22 forward primer 5’-GCG CTG GTC CTC CGG CTC C-3’ and 
reverse primer 5’-CTC GCT GGC GGG GCT TGG-3’; thymidine kinase (TK) forward 
primer 5’-GCC GCC GTA CTG GAC ATG CG-3’ and reverse primer 5’-GCC GAG 
TCC CCG TAA GGC GAT-3’; bTIF forward primer 5’-CCC AAG CCC CGT TCG 
CAG C-3’ and reverse primer 5’-TGC CCG CCC GCC CTT AGA A-3’; glycoprotein C 
(gC) forward primer 5’-GAG CAA AGC CCC GCC GA AGG A-3’ and reverse primer 
5’-TAC GAA CAG CAG CAC GGG CGG-3’.  Cellular glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) forward primer 5’-CCA TGG AGA AGG CTG GGG-3’ and 
reverse primer 5’-CAA AGT TGT CAT GGA TGA CC-3’ was used as a control to 
insure equal loading.  PCR products were analyzed on a 1.2% agarose gel. 
 
One-step growth kinetics 
 U2OS or BT cells were plated to 100 mm dishes 16 to 24 hours prior to infection.  
Cells were infected at MOI 1, followed by absorption for 1 hour at 37 C in serum-free 
media.  Cells were then washed with phosphate buffered saline (PBS) and replaced with 
10% serum containing media.  Supernatants containing virus were collected at 8, 16, 24, 
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and 48 hours after infection and subjected to three rounds of freeze-thaw cycles.  
Supernatants were clarified by centrifugation and titered on CRIB cells for plaque assay. 
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RESULTS 
 
Expression profiles of wt and a mutant BHV-1 in normal or cancer cells. 
 To examine the kinetics of wt BHV-1 and the 51g mutant virus in these cultured 
cell subsets, we analyzed viral gene expression by measuring transcript levels of viral 
genes.  During BHV-1 productive infection, viral genes are temporally regulated and 
classified as immediate early (IE), early (E), or late (L) genes.  Genes representative of 
each gene class were selected and mRNA transcript levels detected by RT-PCR.  Primers 
from previous studies were used to detect transcripts of the IE genes bICP0, bICP4, and 
bICP22, E gene TK, and L genes bTIF and gC.  Primary bovine turbinate (BT) cells and 
human osteocarcinoma (U2OS) cells were infected at an MOI of 1 and RNA was 
extracted after 4, 8, 16, or 24 hours of infection.  Reverse transcription PCR was 
performed and expression of viral transcripts normalized to cellular GAPDH levels.  
Viral transcripts were readily detected in both U2OS and BT cells infected with wt BHV-
1 or the 51g virus (Figure 1).  Transcript levels of the genes analyzed appeared to be 
generally higher in U2OS cells infected with wt BHV-1 compared to 51g infected cells, 
especially at 4 and 8 hours after infection (Figure 1A).  This result was opposite to what 
was observed in BT cells at these time points (Figure 1B).  At 16 and 24 hours post 
infection (hpi) in U2OS and BT cells, all transcript levels analyzed, with the exception of 
bTIF, were expressed at comparable levels by both viruses (Figure 1A and 1B).  Viral 
genes bICP22, gC, and to a slightly lesser extent TK were expressed at similar levels by 
both viruses at all time points in U2OS and BT cells (Figure 1A and 1B).  Results from 
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these experiments did not appear to particularly agree with our hypothesis, but were 
inconclusive due to reversion or contamination of the 51g mutant virus.  Upon noticing 
phenotypic growth changes of the 51g mutant, viral genomic DNA was extracted, the 
region containing the mutation amplified by PCR, and sent for sequencing.  Sequencing 
results revealed loss of the 51g mutation, explaining the inconsistency in our results.  
Thus, we are unable to draw definitive conclusions from these experiments at the current 
time.  In addition to BT and U2OS cells, a murine teratocarcinoma cell line (p19) was 
also examined; however, viral transcripts were not detected from these cells infected with 
either virus, indicating these cells were not permissive for BHV-1 infection (data not 
shown). 
 
Growth kinetics of BHV-1 and 51g in normal and cancer cells. 
The growth kinetics of wt BHV-1 and the 51g mutant virus in normal or cancer 
cells was then evaluated by plaque assay.  U2OS and BT cells were infected at MOI of 1 
in serum-free media followed by replacement with media containing 10% serum after one 
hour incubation.  Supernatants containing virus produced from the infected cells were 
collected at 8, 16, 24, and 48 hpi and subjected to three rounds of freeze-thaw cycles.  
Supernatants were cleared by centrifugation and titers for plaque assay were performed in 
CRIB cells.  Results of titers from two independent experiments in U2OS and BT cells 
are shown in Figure 2.  We observed that the 51g mutant grew at slightly higher titers in 
U2OS cells than BT cells compared to wt BHV-1 at earlier times after infection (Figure 
2A).  By 24 hpi, the 51g mutant and wt BHV-1 produced similar titers in U2OS cells 
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(Figure 2A).  Conversely, in BT cells, higher titers of wt BHV-1 were observed 
compared to the 51g virus (Figure 2B).  This observation suggests that the 51g mutant 
may replicate more efficiently in U2OS cells than wt BHV-1.  In both cell lines tested, 
the 51g virus had reduced growth potential compared to wt BHV-1 which had increased 
titers over time (Figure 2A and 2B).  The 51g virus produces well-defined plaques that 
fail to spread (Saira et al., 2008).  Therefore, impaired cell-to-cell spread of the 51g virus 
could partially explain the reduced growth kinetics observed in these experiments (Figure 
2).  Because we do not know exactly when the 51g mutant virus reverted, these 
experiments must be repeated to confirm these results.  Nonetheless, these experiments 
do confirm that BHV-1 can grow in U2OS cells, but at reduced levels compared to 
infected permissive bovine BT cells. 
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DISCUSSION 
The restriction of BHV-1 replication in bovine cells (Murata et al., 1999), the 
observation that disruption of type I and type II IFN signaling in mice abolishes this 
restriction (Abril et al., 2004), and the ability of BHV-1 to preferentially replicate in 
transformed cells with defects in their IFN pathway (Hammon et al., 1963; Rodrigues et 
al., 2010) suggest that the IFN response serves as an effective barrier to infection by 
BHV-1 and may contribute to its ability to infect transformed cells outside of its host 
range.  A recent study failed to correlate cellular IFN signaling status and permissiveness 
for BHV-1, and instead suggested that BHV-1 replication may be particularly sensitive to 
cell cycle regulation (Rodrigues et al., 2010).  What determines BHV-1 host restriction 
and the mechanism by which BHV-1 induces oncolysis of human cells remains to be 
elucidated, but these phenomena likely depended on a collection of different factors 
including both IFN signaling and cell cycle regulators.   
BHV-1 genomes that fail to express the bICP0 protein or contain mutations within 
the zinc RING finger domain of bICP0 (51g) have defective replication and virulence 
properties in cattle, and are not stable in culture (Geiser et al., 2005; Saira et al., 2008).  
The 51g mutant virus grows poorly in permissive bovine cells under culture conditions 
(Saira et al., 2008).  Calves infected with 51g produced 2 to 3 logs lower levels of 
infectious virus, exhibited reduced clinical symptoms, and did not reactivate from latency 
following dexamethasone infection which induces reactivation in cattle 100 percent of 
the time (Saira et al., 2008).  BHV-1 viruses that are less virulent and that do not 
reactivate from latency are attractive candidates for the development of better BHV-1 
118 
 
vaccines and safer oncolytic viral vector-related therapies.  Propagation of growth 
defective viruses, such as 51g, remains to be a challenge.  While wt BHV-1 is readily 
propagated in culture, it is difficult to obtain high titers of the 51g mutant virus and 
consequently, repeated passage and concentration of the virus is necessary.  We were 
interested to see if cells with known defects in their IFN signaling could alleviate the 
reduced growth potential of the 51g virus.  These studies confirm that BHV-1 and the 51g 
mutant virus can grow in U2OS cells and viral gene expression could be readily detected, 
albeit at reduced levels compared to infected permissive bovine (BT) cells (Figures 1 and 
2).   
The impaired growth ability of 51g increases the selective pressure for mutations 
that rescue this growth defect.  During the course of these studies, the phenotypic growth 
properties of the 51g mutant became less apparent; therefore, sequencing of the viral 
genomic DNA of the mutant was performed to verify the presence of the 51g mutation.  
The sequencing results revealed loss of the 51g mutation on two separate occasions.  
Reversion of the 51g mutation to wild type was an impediment to the progress of these 
experiments and thus, additional experiments are warranted to validate the results 
obtained and presented in this chapter.  The instability of the mutation within this highly 
conserved functional motif clearly indicates that the preservation of this cysteine residue 
is crucial for the integrity of the zinc RING finger domain.  Moreover, the phenotype of 
the 51g virus further underscores the significant role bICP0 plays in the success of viral 
infection and the requirement of this particular motif for the critical functions of bICP0. 
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FIGURE 1  
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Figure 1.  Expression profiles of wt and a mutant BHV-1 in cancer or normal cells.  
Human osteocarcinoma (U2OS) cells (A) and primary bovine turbinate (BT) cells (B) 
were infected with wt BHV-1 or the 51g virus.  RNA was extracted from infected and 
mock infected cells at the indicated times after infection and RT-PCR performed.  PCR 
products were analyzed on a 1.2% agarose gel.  The viral transcripts evaluated are 
denoted on the right, and the class of each gene is indicated on the left.  Cellular GAPDH 
was used to insure equal loading. 
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FIGURE 2 
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Figure 2.  Growth of BHV-1 and the 51g mutant in normal and cancer cells.  U2OS 
cells (A) and BT (B) were infected at 1 MOI with wt BHV-1 or the 51g virus.  
Supernatants containing virus produced from the infected cells were used for viral 
titration and plaque assay.  Graphs represent two independent experiments for each cell 
type. 
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GENERAL CONCLUSIONS 
 
BHV-1 is an economically important pathogen of cattle and although vaccines are 
available, better vaccines are warranted.  Current modified live vaccines cause immune 
suppression in cattle and can lead to serious disease in young calves and abortions in 
pregnant cows (Jones and Chowdhury, 2007; van Drunen Littel-van den Hurk, 2006).  
Furthermore, these vaccines can reactivate from latency and be transmitted to susceptible 
cattle (Ellis et al., 2005; Muylkens et al., 2007; van Drunen Littel-van den Hurk et al., 
2001).  There has also been interest to develop BHV-1 as a vector to deliver antigens to 
cattle for vaccine purposes, and for use as an oncolytic vector for targeting treatment of 
human cancers (Rodrigues et al., 2010).  Although Alphaherpesvirinae subfamily 
members share similar biological properties, BHV-1 has evolved its own mechanisms by 
which it is able to establish a successful infection.  Further evaluation of the biology of 
BHV-1 is necessary to understand the underlying molecular events related to infection by 
this virus.  Thus, the reasons stated above make BHV-1 biology a relevant area of study.   
BHV-1 encoded bICP0 is a multifunctional protein that is critical for efficient 
replication, virulence, and reactivation from latency (Geiser et al., 2005; Saira et al., 
2008).  A number of important functions have been attributed to bICP0 (Jones, 2009); 
however, the underlying mechanisms by which bICP0 carries out these functions are not 
well understood.  In order to gain insight into the molecular mechanisms and other 
potential functions of bICP0, coaffinity purification of bICP0 and mass spectrometry 
analysis of bICP0 bound proteins was performed.  Although we have not confirmed any 
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novel bICP0 binding proteins from these mass spectrometry results, our initial results 
clearly showed visibly unique protein bands.  This is promising for identifying bICP0 
associating proteins and would contribute to our understanding of the underlying 
functional mechanisms of bICP0.   
The C3HC4 zinc RING finger motif is a critical functional domain of bICP0 that 
possesses intrinsic E3 ubiquitin ligase activity (Diao et al., 2005; Everett et al., 2010).  
Although these studies did not identify any novel proteins targeted by bICP0 for 
ubiquitination, they did demonstrate that bICP0 increases the level of protein 
polyubiquitination.  These studies also demonstrated that an intact zinc RING finger 
domain is important for regulating bICP0 protein stability, potentially by catalyzing its 
own ubiquitination.  Other sequences toward the C-terminus of bICP0 also appear to play 
a role in stability of the bICP0 protein.  These studies demonstrated that deletion of 
sequences at the C-terminus of bICP0 alters bICP0 localization, levels, and cell 
morphology (Gaudreault and Jones, 2011).   
PML protein levels were dramatically reduced in a proteasome-dependent manner 
in bovine cells following infection with BHV-1 or expression of bICP0 in the absence of 
other viral genes (Gaudreault and Jones, 2011).  Because the underlying function of PML 
is still unclear, it is difficult to exactly define what the reduction of PML does for the 
virus.  However, PML is known to promote apoptosis (Bernardi and Pandolfi, 
2003;(Giorgi et al., 2010) and antiviral responses (Everett and Chelbi-Alix, 2007; 
Geoffroy and Chelbi-Alix, 2011; Tavalai and Stamminger, 2008), and these studies 
demonstrated that over-expression of PML appears to correlate with reduced BHV-1 
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replication.  Although the zinc RING finger domain was found to be important for 
efficient PML degradation, altering the localization of bICP0 did not appear to affect its 
ability to reduce PML levels.  This suggests that either bICP0 induces degradation of 
PML by an indirect mechanism or that bICP0 interacts with PML in the cytoplasm.  
Cytoplasmic PML has been shown to be important for regulating apoptosis (Giorgi et al., 
2010) and in the resistance to viral infections (McNally et al., 2008), giving precedence 
for bICP0 to interact with PML in the cytoplasm.   
Furthermore, bICP0 was found to be present in the cytoplasm of primary low-
passage bovine cells at later times of BHV-1 productive infection (Gaudreault and Jones, 
2011).  This implicates a role for cytoplasmic bICP0 during infection, and suggests late 
viral proteins or induced factors may sequester bICP0 to the cytoplasm of productively 
infected cells.  Recently, other work from our lab has shown cytoplasmic bICP0 can 
inhibit IFN- promoter activity and induce degradation of IRF3 as efficiently as wt 
bICP0 (Da Silva and Gaudreault, unpublished).  Thus, this data suggests a role for 
cytoplasmic bICP0 in repressing the innate immune response and altering cell fate after 
infection.   
Attempts were also made to determine if the impaired replication potential of the 
bICP0 zinc RING finger mutant virus (51g) could be rescued in cells with defects in their 
IFN signaling.  Although the reversion of the 51g mutation to wild type was an 
impediment to the progress of these experiments, the instability of the mutation within 
this highly conserved functional motif clearly indicates that the preservation of this 
cysteine residue is essential for the integrity of the zinc RING finger domain.  Moreover, 
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the phenotype of the 51g virus further underscores the significant role bICP0 plays in the 
success of viral infection and the requirement of this particular motif for the critical 
functions attributed to bICP0. 
In conclusion, the studies presented in this dissertation provide further evidence 
that will contribute to a better understanding of the role of BHV-1 encoded bICP0 during 
productive infection and the mechanisms underlying its critical functions.   
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